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ABSTRACT
The Endoplasmic Reticulum (ER) plays a pivotal role in cellular functioning.
Proteins undergo modifications in the ER. The cell monitors protein folding and
has a quality control. The incorrectly folded proteins are tagged for degradation
or sent back to the refolding cycle. Upon accumulation of incorrectly folded
proteins in the cell, due to any alterations in the cellular homeostasis, cellular
stress is created. This leads to a cascade of events, termed the Unfolded Protein
Response (UPR). Cellular stresses range from hypoxia, nutrient deprivation to
external stimulus such as heat or radiation. It is vital to understand the com-
plexities involved in this system, to predict the role of UPR in cancer, diabetes
and other diseases associated with misfolded proteins. In the current study, we
have created an initial model of the UPR. This model is based on mass action
kinetics. We solve this model deterministically, to look at the concentration pro-
files of the proteins and protein complexes, upon UPR induction. This kind of
study, along with the mathematical and statistical tools developed in the Varner
lab provide tools to identify fragile elements of the UPR network. These fragile
components of the system become targets for intervention by drugs and inform
the development of experiments to discover new pharmaceutical treatments.
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teins are then the substrates of UDP glucose:glycoprotein glu-
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to fold in a repeated number of cycles, the mannose residue
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be recognized by ER-degradation-enhancing 1,2-mannosidase-
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CHAPTER 1
INTRODUCTION
The Endoplasmic Reticulum (ER) plays a key role in cellular functioning,
from cell survival to cell death. Some of the key processes for proper function-
ing of the cell are maintenance of calcium homeostasis, protein synthesis and
lipid biosynthesis. The unique environment of the ER holds the key to most of
these processes. ER has the highest concentration of Ca2+. It also has a high
concentration of Ca2+-dependant molecular chaperones which are required to
stabilize protein folding intermediates. The oxidative environment in the ER
aids in formation of disulphide bonds, which is essential in the folding of pro-
teins. Besides the ability of the ER to aid in glycosylation and lipidation, it also
functions as a signalling organelle by means of releasing Ca2+ through the ion
channels.
Any alterations to the ER environment is treated as stress in the cell. Hy-
poxia leads to alterations of the cellular redox regulation. This is one form of
cellular stress which is common to tumor or cancerous cells. Glucose depriva-
tion, aberration of calcium regulation, viral infection, high fat diet, smoking,
neuro-degenerative diseases are some of the instances that have been shown in
the literature to induce ER stress. These stresses lead to triggering of an evolu-
tionarily conserved pathway called Unfolded Protein Response (UPR).
Broadly UPR performs three types of functions, adaptation, alarm and apop-
tosis. Initially the UPR tries to re-establish homeostasis in the cell by induc-
ing transcriptional programs, leading to expression of chaperones that enhance
protein folding. Simultaneously, translation of mRNAs is inhibited to reduce
the protein load on the ER. If the adaptation step is not sufficient, the UPR in-
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duces an alarm to the cell. This alarm is representative of the signal transduc-
tion events, leading to activation of JNK (Jun N-terminal Kinase), p38 MAPK
(mitogen-activated protein kinase), and NF-κB (transcription factor nuclear fac-
tor - κB). These signaling events activate downstream proteins involved in cel-
lular immunity and defense. If all these adaptive motions fail to compensate for
the ER stress, cellular death (apoptosis) is induced. Apoptosis could be either
caspase-dependent or caspase-independent. ER stress is also seen to initiate
autophagy.
The target of this project was to identify the governing interactions in the
UPR network from the literature and to model these interactions using a deter-
ministic approach. A fully functional model of the UPR could in fact provide
us a closer look at the key elements of this network. The aim of this study is
to identify these key aspects of the network. This information shall help us to
prioritize new experiments and to obtain key targets for drug development.
This information could be gained by doing a sensitivity analysis of the net-
work and by edge-coupling studies which would function as a knockout study
in the experimental sense. One key challenge faced in this kind of study is to
identify the rate constants for the interactions which are not available in the lit-
erature. To target this issue, we are using a multiple objective thermal annealing
scheme, in addition to hand-fitting the model to certain experimental observa-
tions made in the literature.
Using these techniques we have been able to generate a family of models
that best describe, qualitatively, the Unfolded Protein Response.
2
CHAPTER 2
UNDERLYING BIOLOGY OF THE UNFOLDED PROTEIN RESPONSE
AND ITS DOWNSTREAM EFFECTS
Throughout the lifetime of a cell, it is subjected to varied sources of stress.
Radiation, hypoxia, nutrient deprivation, free radicals accumulation, toxins and
microbial pathogens are a few sources of ER stress. These could either be miti-
gated by the cells’ protective machinery or could lead to cell death and irrevoca-
ble damage. To manage these exogenous forms of stress, the cell has developed
specific pathways to counteract its effects.
One of the key locations for cellular stresses to manifest themselves is in
the ER. The primary source of stress in the ER is the accumulation of unfolded
proteins. Newly synthesized proteins enter the ER through the SEC61 channel
in the ER membrane. Upon entering, the protein attains a three dimensional
conformation followed by post translational modifications. Some of the key
modifications include disulphide bond formation and N-linked glycosylation.
After these modifications, a protein can be labeled as being correctly folded, if
it has attained its native conformation. In case the environment in the cell is
not right for folding, there is an accumulation of unfolded proteins in the cell.
The phenomenon initiated by the accumulation of unfolded proteins is known
as the Unfolded Protein Response (UPR).
UPR was initially studied extensively in yeast cells. In yeast, it is primar-
ily controlled by one pathway. Higher organisms have a highly evolved three-
pronged signal transduction pathway for UPR. In normal cells, the cell has a
Quality Control, which ensures the correctly folded state of the proteins. In-
correctly folded proteins are removed from the ER by means of ER Associated
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Degradation (ERAD). In case there is an overload of unfolded proteins, UPR
is initiated to induce translation attenuation and selective transcription of cer-
tain proteins (e.g. molecular chaperones). In case the overload is not resolved,
apoptosis or autophagy is induced to destroy the cell. The following chapter
details the underlying biology in the above mentioned aspects of the cellular
functioning.
2.1 Protein Folding and Quality Control in the cell
It is vital for a cell’s proper functionality to have the proteins in the correctly
folded state. The process by which the quality of the proteins in a cell is main-
tained is termed as Quality Control (QC)[41].
Proteins are synthesized and mature in the ER. The molecular chaperones
and the folding factors in the ER plays a major role in the QC [41]. Some of the
vital chaperones playing a role in the folding process are enlisted in table 2.1.
Certain cotranslational and post-translational modifications take place in the
ER. Cotranslational modifications occur as the protein enters the ER through
the proteinaceous channel known as the translocon complex. This is followed
by the post-translational modifications taking place in the ER lumen. Some of
these modifications include disulphide-bond formation, signal-peptide cleav-
age and N-linked glycosylation. Finally, oligomeric assembly takes place for
these modified proteins. The delicate balance of the folded and unfolded state
of the protein is depicted in figure 2.1.
The QC, ensures that a premature exit of the proteins in the unfolded state
is restricted. In general, QC occurs in two phases. In primary QC, all the pro-
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Table 2.1: The key chaperones of the endoplasmic reticulum
Chaperone Family Detials
HSP70s BiP and GRP170 are the members of
this family. BiP plays a key role in
the binding and assists the folding of
nascent proteins. It also plays a cen-
tral role in ERAD and UPR.
HSP40s ERdj1-5 are the members of this fam-
ily. They stimulate BiP ATPase activ-
ity invitro
HSP90 GRP94 is the only known member of
this family. Its role in UPR is still not
substantiated.
Calnexin and Calreticulin These proteins are instrumental in
the folding of proteins that have
monoglucosylated N-linked glycans.
Thiol-disulphide oxidoreductases Protein disulphide isomerase is a
member of this group. It cataly-
ses and leads to oxidation, isomeriza-
tion and reduction of the disulphide
bonds.
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Figure 2.1: Effect of the ER environment in Protein Folding: Chaperones
play a key role in the equilibrium between the correctly folded
and unfolded proteins in the ER. Chaperones bind to the incor-
rectly folded proteins and inhibit aggregation, thereby promot-
ing folding. They also play a role in targeting unfolded proteins
for degradation (ERAD).
teins are checked for their folded state [42]. The closeness to the native struc-
ture, could be used as a measure for protein folding. The presence of exposed
hydrophobic regions, unpaired cysteine residues, and the ability to aggregate
could be some of the markers to measure the deviation from the native state of
the protein. This deviation is sensed by chaperones such as: BiP, calnexin, cal-
reticulin, glucose-regulated protein (GRP 94), thiol-disulphide oxidoreductases,
protein disulphide isomerase (PDI) and ERp57. These chaperones bind to the
proteins that have not folded correctly [46, 66, 67]. This binding increases the
time the protein spends in the ER lumen, giving it a chance to fold correctly.
This process is depicted in the figure 2.2 for the case of glycoproteins.
There are some exceptions to this proposed system [55, 124]. As these pro-
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Figure 2.2: Importance of calnexin/calreticulin in the protein folding cy-
cle. Yellow circles attached to the protein denote Glucose
groups and blue circles denote Mannose group. After entering
the ER lumen, glucosidase I and II remove two glucose groups.
The monoglucosylated glycoprotein, then interacts with cal-
nexin/calreticulin. These chaperones interact with the thiol-
disulphide oxidoreductase ERp57. Cleavage of the last glucose
residue by glucosidase II, leads to the release of the chaper-
ones. At this time, the protein could have either folded and
left the ER or it could have attained an incorrectly folded state.
The incorrectly folded proteins are then the substrates of UDP
glucose:glycoprotein glucosyltransferase, which puts a glucose
residue back to the incorrectly folded protein. This step en-
ables the protein to spend some more time in the ER to fold
correctly. If the protein fails to fold in a repeated number of cy-
cles, the mannose residue is removed by α-1,2-mannosidase I.
This enables the protein to be recognized by ER-degradation-
enhancing 1,2-mannosidase-like protein (EDEM). This targets
the unfolded proteins for ER-associated degradation (ERAD).
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teins are bound to the chaperones, they go through the calnexin/calreticulin
cycle. Calnexin and calreticulin bind specifically to monoglucosylated gly-
can (Glc1Man7-9GlcNAc2) (Glu - Glucose, Man - Mannose, GlcNAc - N-
acetylglucosamine) [212, 110, 65, 169]. ERp57 binds to the calnexin complex
[140, 26]. Glucosidase II leads to breaking up of the complex, by hydrolysis of
the glucose from the monoglucosylated core glycan. UDP-glucose: glycopro-
tein glucosyltransferase (GT) reglycosylates the processed protein which allows
reattachment with calnexin/calreticulin [149]. This is selective and only occurs
when there is an improper folding of the protein.
In this way the cycle of glycosylation and deglycosylation leads to the pro-
teins spending sufficient time in the ER to fold correctly. Failure of the above
mentioned cycle leads to targeting of the proteins for ERAD[119].
2.2 ER associated degradation (ERAD)
The major components of ERAD are: recognizing the correct unfolded protein,
targeting the protein for degradation, retro-translocation, ubiquitylation and
proteasomal degradation [205].
There could be many folding aspects that the cell might use to recognize
an incorrectly folded protein. One of these features include the exposure of
hydrophobic patches, which are generally hidden in correctly folded proteins.
Molecular chaperones like HSP70, recognize these exposed patches and bind
to the proteins. This mode of ATP-dependent binding and release of HSP70
ensures that the incorrectly folded proteins do not exit the ER. Co-chaperones
and nucleotide-exchange factor (NEFs) also play a key role as seen in figure
8
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Figure 2.3: Molecular chaperones like HSP70 recognize the unfolded pro-
teins and allow them to spend some time in the ER to undergo
refolding cycles. In case these proteins fail to fold correctly they
are translocated out of the ER where they are tagged by Ubiq-
uitin and ultimately degraded by the 26S Proteasome.
2.3. N-linked glycans and/or di-sulphide bonds are features that are used for
targeting the proteins for ERAD [205].
Once the proteins have been selected, they are retro-translocated into the
cytoplasm. This is where the they are ubiquitylated.
Ubiquitin (Ub) is activated by an E1 Ub-activating enzyme. This step is fol-
lowed by the transfer of the Ub from the E1 to the E2 through the formation of a
thioesters linkage. Now in the presence of E3 Ub ligases this Ub-E2 system can
transfer the Ub to improperly folded proteins. The ubiquitylated proteins are
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now targeted to the 26S proteasome and degraded [205] as seen in figure 2.3.
During ER Stress, QC and ERAD fail to manage the high loads of protein
and this leads to accumulation of unfolded proteins in the ER. This condition
initiates UPR. Owing to accumulation of the unfolded proteins in the cell, the
ER resident chaperone (BiP) break free from the ER stress transducers. These
ER stress transducers are located in the ER membrane, with their N-terminals
in the ER and their C-terminals in the cytosol. The chaperones released from
these transducers are now employed in protein folding. There are competing
theories about the activation of these transducers. Some say that the release of
the chaperones lead to the activation of these transducers, while other believe
its direct activation by unfolded proteins. Some of these theories are discussed
in the following sections. PRKR-like ER kinase (PERK), inositol-requiring ki-
nase 1 (IRE1) and activating transcription factor 6 (ATF6) are the key ER stress
transducers.
2.3 Inositol-requiring kinase 1 (IRE1) branch of UPR
IRE1 is a type I transmembrane protein serine/threonine present in the ER
membrane. This 100 kDa protein has an endoribonuclease domain along with
a Ser/Thr kinase domain. IRE1 exists as two homologues: IRE1α and IRE1β.
IRE1α is expressed ubiquitously [195]. IRE1β is found in the intestinal epithelia
[195, 209]. The N-terminal of IRE1 located in the ER lumen is the key in sensing
the overload of unfolded proteins [25, 171, 182].
IRE1 is activated by the homooligomerization or homodimerization [171,
214]. This activation is mediated by the luminal domains in the ER. Cytosolic
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Figure 2.4: Two competing models for the activation of IRE1 and PERK are
known. In Model 1, release of BiP from the ER transducers by
competitive binding to the unfolded proteins lead to activation
of the ER stress transducers. In Model 2, unfolded proteins
directly lead to the activation of the ER stress transducers. In
the current study, we are using model 1.
parts of the IRE1 also facilitates the activation [214].
Two models have been presented for activation of IRE1 and PERK as in fig-
ure 2.4. According the the first model, upon UPR induction, BiP is sequestered
away from the luminal domain of IRE1 and PERK [87]. In unstressed cells, BiP
forms a complex with the luminal domain of IRE1 and PERK [9, 139, 109] which
undergoes dissociation upon ER stress [9, 139]. It was also shown that overex-
pression of BiP would lead to reduced activation of IRE1 and PERK [9, 88].
The second model states that IRE1 can directly sense the amount of folded
proteins. This argument is based on the presence of the peptide binding domain
in the IRE1 which leads to interaction with unfolded proteins [109, 108].
UPR induction leads to activation of the IRE1 by autophosphorylation of the
kinase domain [171, 214, 213, 146]. This activation enables the endoribonuclease
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domain to cleave the XBP1-mRNA [176, 227, 102]. This cleavage occurs both at
the exon-intron junctions in the XBP1-mRNA. The spliced XBP1-mRNA is trans-
lated to produce a 41 kDa XBP1 protein (XBP1s) as seen in figure 2.5. Upon UPR
activation we find that there is rapid proteasomal degradation of the XBP1 that
has not been cleaved [99, 229]. Homodimerization of XBP1s with NF-Y leads to
binding of this complex with several UPR genes [113, 158]. IRE1α directly plays
a key role along with XBP1 in cleaving several proteins to balance the role of
proteins in the ER [72].
Phosphorylated IRE1α is dephosphorylated by protein phosphatase two C 2
protein (Ptc2P) [195]. A proper feedback control loop for the IRE1 pathway has
yet to be defined.
IRE1 also functions as a protein kinase. IRE1 binds the tumor necrosis fac-
tor(TNF) receptor associated factor 2 (TRAF2) as seen in figure 2.5. This has been
shown to play a major role in the JNK activation [203, 134]. JNK activation leads
to activation of pro-apoptotic BIM [103, 154] and inhibiting Bcl2 [220]. BIM in
normal cells is sequestered in motor complexes interacting with the cytoskele-
ton [103]. Upon JNK activation BIM is detached from the motor complexes and
this leads to BAX/BAK dependant apoptosis as seen in figure 2.6.
It has been found that IRE1 directly interacts with caspase 12 [223] which
has a key role in UPR induced apoptosis. Humans do not show the presence of
caspase 12. It has been argued that caspase 4, which a close counterpart to cas-
pase 12 play a role in ER stress induced apoptosis [71]. It was also shown that
caspase-4 activation was affected by Bcl2 overexpression. The results stated that
caspase-4 activation takes place due to ER-stress but the relation with the effec-
tor caspases has not been established [71]. This claim has partially been sub-
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Figure 2.5: Upon UPR induction, IRE1 is activated. This leads of cleavage
of the XBP1-mRNA, leading to production of a 41kDa XBP1
proteins (XBP1s). XBP1s along with NF-Y binds with several
UPR genes. Activated IRE1 also binds with tumor necrosis fac-
tor(TNF) receptor associated factor 2 (TRAF2) leading to acti-
vation of JNK downstream. This step is instrumental in initiat-
ing apoptosis downstream.
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Figure 2.6: This schematic represents JNK-dependant apoptosis signaling
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to the release of Bim, Bmf from the dyenin and myosin V mo-
tor complexes. The activated Bim, Bmf could directly lead to
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lead to the activation of Bax/Bak. This downstream leads to
the mitochondria mediated apoptosis.
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stantiated in a few of cell types [40]. IRE1 directly plays a role in the apoptotic
pathway downstream by interacting with BAX and BAK [69].
2.4 PRKR-like ER kinase (PERK) Pathway
PERK is a type I transmembrane protein, consisting of a ER luminal stress sens-
ing domain and a cytosolic protein kinase domain. The C-terminal protein
kinase domain shares homology to the EIF2α kinases, PKR, GCN2 and HRI
[63, 179, 178]. Activation of PERK follows the same models as discussed in the
activation of IRE1. This activation leads to the phosphorylation leading to acti-
vation of the kinase domains. This downstream leads to the phosphorylation of
the eukaryotic translation initiation factor 2α (eIF2α) as seen in figure 2.7.
Phosphorylation of eIF2α plays a three-fold role downstream. The first effect
is reduction in general translation. This is followed by an increase in the clear-
ance of the accumulated proteins in the ER by ERAD. Selective translation of
mRNAs takes place, for example, mRNA for the bZIP transcription factor ATF4
[111]. ATF4 targets the genes that encode for GRP78 and GRP94 [64]. The role
of this branch is to degrade the accumulated proteins and improve protein fold-
ing. It has been shown that PERK −/− cells are extremely sensitive to ER stress
[62, 168].
The role of PERK in apoptosis has not been clearly defined. It has been
shown that it can induce autophagy [92, 49]. There is evidence to support that
PERK delays the onset of the apoptotic branch of UPR. It has been demonstrated
that the PERK branch of apoptosis leads to the induction of cellular inhibitor of
apoptosis (cIAPs) [58]. This evidence goes a long way in establishing a pro-
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Figure 2.7: Upon UPR induction, PERK is activated which leads to phos-
phorylation of eIF2α. This step has a three fold effect down-
stream, which leads to reduced translation, increased ERAD
and selective translation of certain proteins like ATF4.
survival role of the PERK branch. The exact mechanism has not been under-
stood, though the phosphorylation of AKT has been suggested to play a role
[58]. It shall be interesting to note the relation between apoptosis the PERK
branch of UPR.
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2.5 Activating transcription factor 6 (ATF6) branch of UPR
ATF6, is a type II ER transmembrane protein that is normally located on the
ER membrane. This positioning is enabled by the ER-targeting hydrophobic se-
quences. The cytosolic component of the protein encodes a bZIP transcription
factor [183]. ATF6 (90 kDa) is synthesized in the ER in two homologous forms:
ATF6α [183, 56] and ATF6β [123, 85, 96]. Upon ER stress the actions of ATF6 are
broadly different from the IRE1 and PERK branches of UPR. ER stress leads to
the release of the GRP78 (BiP) from ATF6. Following this, ATF6 is translocated
to the Golgi Complex [20] as in figure 2.8. In the golgi, it is cleaved in the luminal
domain by serine protease site-1 protease (S1P) [183]. This is further followed
by a cleavage by the metalloprotease site-2 protease (S2P) [183, 222, 174] as in
figure 2.8. This cleavage phenomenon is called Regulated Intramembrane Prote-
olysis (RIP). This cleavage at the juxtamembrane site allows the transcriptional
domain of ATF6 to be released to the cytosol. The domain (50kDa) compriz-
ing of the bZIP region of ATF6, migrates to the nucleus leading to regulation of
gene expression [222]. Some of the known binding sites for the cleaved ATF6
domains are ATF/cAMP response element (CRE) [211] and the ER stress re-
sponse elements (ERSE) I and II [226, 89]. This binding action is controlled by
the nuclear factor Y (NF-Y) [89, 228].
ATF6β has been reported to be heterodimerized upon BiP control [194].
There have been reports of ATF6β to play roles of transcriptional activation [96]
but weaker in strength compared to ATF6α. This might have a role in the con-
trol of activation of ATF6α [221, 192]. The mechanism of the BiP interaction with
ATF6 is still on shaky grounds. Golgi localization sequences (GLS1 and GLS2)
seem to be instrumental in playing a key role in the BiP action on ATF6. It was
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Figure 2.8: Upon UPR induction ATF6 transmigrates to the golgi body,
where it is cleaved by S1P and S2P protease. The cleaved ATF6
part moves to the nucleus, where it binds to the ER stress re-
sponse elements (ERSE) I and II.
noted that BiP binding to GLS1 was the reason for the retention of ATF6 in the
ER [173]. Upon release of BiP in case of ER stress, the GLS2 domain targeted the
movement of the ATF6 to the Golgi body [173]. Recently, it has been shown that
ER stress leads to the restarting of the BiP ATPase cycle. This leads to the disso-
ciation of BiP from ATF6 [175]. CRT, a lectin, also might have a role in keeping
the ATF6 in the ER [73]. There are still many unanswered questions in the exact
mechanism for ATF6 transport from the membrane to the Golgi body.
The cleaved ATF6 stimulates ER stress genes by homodimerization or het-
erodimerization with other bZIP transcription factors. Some of the target genes
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for cleaved ATF6 domains are GRP78, PDI and ER degradation-enhancing
alpha-mannosidase-like protein 1 (EDEM1). These actions lead to an increase
in the chaperone activity and degradation of unfolded proteins [221, 215].
Downstream effect of ATF6α also includes a cytoprotective response, includ-
ing the regulation of regulator of calcineurin 1 (RCAN1) [6]. Calcineurin is a cal-
cium activated protein-phosphotase B. It plays a role in the control of the Bcl2
proteins and Bcl2-antagonist of cell death (BAD). Calcineurin dephosphorylates
BAD, allowing it to dimerize with Bcl2 [208]. This set of actions is proapoptotic.
The role of RCAN1 is to act as an endogenous inhibitor of calcineurin [6].
ATF6 family of transcription factors includes CREG3L2, CREB-H, LUMAN
(CREB3) and OASIS [52]. The role of these family members in ER stress is yet to
be documented.
2.6 UPR mediated CHOP Induction
Growth-arrest and DNA-damage-inducible gene 153 (GADD153) is normally
present in low numbers in the mammalian cells [165]. GADD153 also known
as CHOP is a 29kDa protein consisting of 169 amino acids in humans. The
GADD genes are induced generally during genotoxic stress signals and growth
arrest signals. Perturbations in the ER homeostasis leads to induction of CHOP
and accumulation in the nucleus. CHOP protein comprises of an N-terminal
transcriptional activation domain and a C-terminal basic-leucine zipper (bZIP)
domain. The bZIP domain plays a key role in the homodimerization of the
protein [117, 118]. CHOP is phosphorylated by the p38 MAPPP kinase family
of proteins [210, 118]. MAPKKK ASK1 is required for JNK activation in the IRE1
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branch of UPR [134, 196]. This can lead to the activation of the p38 MAP kinase
[134]. ASK1 null cells do not show ER-stress induced apoptosis [134].
CHOP is shown to be one of the highest inducible genes during ER stress
[177]. The idea is that CHOP plays a key role downstream of all the 3 pathways
that are initiated by the ER stress. CHOP promoter region in humans has two
ERSE motifs and one AARE motif [228, 201, 17]. ATF4, which is induced by the
PERK branch of UPR, binds to the AARE domains of the CHOP gene. PERK
null cells show almost zero induction of CHOP and ATF4 [168, 60], suggesting
the dominance of the action of ATF4 and CHOP genes. On the other hand, we
see weak interaction between the ATF6 and IRE1 branches and the CHOP gene.
Studies related to CHOP overexpression have revealed that it leads to re-
duced Bcl2 protein concentrations. Similarly, overexpression of Bcl2 prevents
apoptosis induced by CHOP [117, 120]. It has been shown that CHOP protein
is instrumental in translocation of BAX from the cytosol to the mitochondrion
[54]. The direct role of CHOP protein with Bcl2 has not yet been established.
2.7 ER Stress and Autophagy
Studies indicate that the ER stress triggers autophagy [137, 224, 7, 82, 74, 92,
49]. PERK, IRE1 and excess of free cytosolic Ca2+ play key roles in initiating
autophagy in ER stressed cells [137, 74, 92, 49].
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Figure 2.9: Upon ER stress, a part of the cytosol, organelles or both are
engulfed in a double membrane. This structure is called Au-
tophagosome. This leads to the formation of an autolysosome,
which is degraded to complete the cycle of autophagy.
2.7.1 General machinery of Autophagy
Autophagy, in the classical sense, is the method by which a cell recycles its
macromolecules and its organelles. This process is initiated by the formation
of an autophagosome. Autophagosome comprises of a part of the cytosol or
cellular organs or both, bound by a double membrane [104, 93, 22] as in figure
2.9. This autophagosome then binds to the endolysosomal vesicles leading to
the creation of the autolysosome. This autolysosome is then degraded, com-
pleting the cycle of autophagy.
The key proteins playing a role are class III phospha-tidylinositol 3-kinase
(PI3K), p150 myristylated protein kinase and beclin 1 (atg6). These proteins are
involved in the nucleation and formation of the autophagosomal membrane.
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This is followed by the elongation of this membrane by two-ubiquitin-like con-
jugation systems. This step is marked by the conversion of the free form of the
microtubule-associated protein 1 light chain 3 (LC3 also called atg8), LC3-I to
membrane-bound form LC3-II. LC3-II serves as the marker for the initiation of
autophagy.
The autophagy branch in eukaryotic cells is inhibited by the mammalian tar-
get of rapamycin complex 1 (mTORC1) protein complex [136, 121]. This com-
plex consists of mammalian target of rapamycin (mTOR), regulatory associated
partner of mTOR (raptor) and mLST8 [22, 167, 23].
2.8 UPR mediated apoptosis
Apoptosis is a type of cell death program that maintains tissue homeostasis in
multicellular organisms and regulates immune response. Mutations that im-
pair apoptosis often lead to diseases such as autoimmune disorders and cancer.
Apoptosis is characterized by nuclear and cytoplasmic condensation, blebbing
of the plasma membrane and DNA fragmentation [84]. The dying cell even-
tually disintegrates into membrane-enclosed apoptotic bodies. These apoptotic
bodies are quickly destroyed by phagocytes or the neighboring cells. This is in
contrast to Necrosis, which is a pathological dying process involving the un-
natural death of cells and tissue. Apoptosis does not induce the inflammatory
process or cause tissue scarring, which is a hallmark of necrosis. Apoptosis,
thereby, serves as an ideal process for cell elimination in embryogenesis and
tissue homeostasis.
A common biomarker for apoptosis includes the activation of the aspartate-
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specific proteases collectively known as caspases [2]. There are a total of 14
members of the caspase family [191]. Each of them shares the basic structural
homology with the Caenorhabditis elegans cell death protein CED-3. Caspases
contain the conserved pentapeptide active site QACXG(X can be R, Q or D). Cas-
pases are activated from their zymogens (procaspases), in response to various
death cues. TRAIL (TNF-related apoptosis-inducing ligand), Fas, TNFa and ex-
trinsic stress factors such as UV and chemical-agents are some of the death cues.
Caspase function by rapidly dismantling the key cell cycle, cytoskeletal and or-
ganelle proteins by proteolytic cleavage. This makes the dying cell unable to
initiate or maintain normal cellular functions.
The core of the cell-death program consists of three major components: the
Bcl-2 family of proteins, the caspases and the Apaf-1/CED-4 protein. Activa-
tion of these components is vital in the morphological changes observed during
apoptosis.
2.8.1 Critical Role of Caspases
A total of 14 caspases (cysteinyl aspartate-specific proteases) have been iden-
tified in mammals. They can be classified into 3 groups: initiators of apop-
tosis (group I), effectors (group II) and inflammatory caspases (group III) 2.2.
Caspases exist as inactive enzymes analogous to zymogens. Caspases in this
zymogen form are called procaspase and this control is necessary to prevent
unnecessary cell death. Procaspases consist of an N-terminal prodomain struc-
ture, a large 20kDa (p20) subunit and another 10kDa subunit (p10). The p20
and p10 subunits are connected by a linker region in many caspases. Typically,
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Table 2.2: Types of Caspases
Subfamily Role Members
I Apoptosis Initiator Caspase 2, 8, 9, 10
II Apoptosis Executioner Caspase 3, 6, 7
III Inflammatory Mediator Caspase 1, 4, 5
the inflammatory and initiator caspases have large prodomain regions of 100
residues. It has also been noted that effector caspases have small prodomains of
20-30 amino acids [98]. Active caspase is generated by proteolytic processing of
the proenzyme and subsequent release of the prodomain.
2.8.2 Convergence of the apoptotic pathways
Death cues result in the activation of caspases by proteolytic processing of pro-
caspases. In the sequence of events, initiator caspases are activated before the
executioner caspases. The initiator caspases, caspase-8 and caspase-9, can self-
activate themselves upon formation of dimers in response to death cues [126].
The executioner caspases, such as caspase-6, caspase-3 and caspase-7, are acti-
vated by the initiator caspases. Activated executioner caspases can initiate the
activation or inactivation of a number of substrates to facilitate the cell death
process. In addition, executioner caspases can also activate initiator caspases
to form a positive feedback. There are 2 pathways that result in activation of
caspases in response to apoptotic signals, as seen in figure 2.10. They are the
death-receptor mediated and the stress mediated pathways.
24
Caspase-8/-10
Caspase-8/-10
Procaspase-8/-10
Procaspase-8/-10
FADD
TRADD
Fas/APO-1/CD95
FasL
TNFR
TNF
Cytoplasm
Fas/APO-1/CD95 trimerization
followed by linking to FasL and 
recruitment of FADD and Procaspase-8/-10
Casper, I-FLICE, 
FLAME, CASH or MERIT
Apo2 Ligand
TRAIL Receptor
DcR1, DcR2
DcR3
SODD
CrmA
RAIDD
RIP
Procaspase-2
Caspase-2
A
A
Bid
tBid
Cytochrome C
Apaf-1
Procaspase-9
ATP
Apaf-1-Cytochrome C
Complex
Caspase-9
Bcl-2/Bcl-xL
XIAP
NF-KB
DIABLO
/Smac
Caspase-3
ICAD-CAD Complex
Active CAD
Procaspase-6
Caspase-6 Apoptosome
Cleaving
Lamin A
Fodrin
Gas2
Actin
Procaspase-7
Caspase-7
PARP
Caspase-9
DNA Repair
Condensation 
of chromatins 
and 
decomposition 
of nuclear 
membrane
DNA fragmentation
Procaspase-9
DIABLO
/Smac
Procaspase-3
cleaved
PARP
Pro-Caspase-8/-10 Mitochondria
Caspase-3
Caspase-6
Caspase-7
Pores in 
Mitochondria
Bcl-2/Bcl-xL
APOPTOSIS
BAX/BAK
activation
Figure 2.10: Apoptotic pathway in a cell is either Death-receptor mediated
or stress-mediated. Both the pathways converge onto the mi-
tochondria where they finally lead to activation of Caspase 9
and release of DNA damage inducible agents from the Mito-
chondria.
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Death-receptor Mediated Pathway
The first pathway is initiated by ligand-mediated activation of death receptors
on the plasma membrane. These death receptors belong to the tumor necrosis
receptor (TNFR) family. They include Fas receptors (CD95 or APO-1), TNFR1,
TRAIL-R1 (TNF-related apoptosis-inducing receptor-1), TRAIL-R2, DR3, DR4
and DR5 [127, 1, 5]. Fas/CD95 ligand (FasL) binds to Fas. TNF binds to TNFR1.
Apo3 ligand (Apo3L) binds to DR3. Apo2 ligand (Apo2L or TRAIL) binds to
DR4 and DR5 [5]. Binding of the ligand to the receptor generates intracellular
signals, leading to caspase activation.
There are three distinct steps involved in the process. In the first step, ligand-
induced receptor trimerization takes place, as seen in figure 2.10. This is fol-
lowed by the recruitment of adaptor proteins to activate the receptors. Recep-
tor activation recruits adaptor proteins like FADD (Fas-associated death do-
main) and TRADD (TNFR1 death domain associated protein). Other adaptor
proteins like RIP (Receptor interacting protein), RAIDD and MADD have also
been identified. The adaptor proteins contain DEDs which facilitate interac-
tions between adaptors and activated death receptors. The exposed DED of the
procaspase-8 interacts with the DED of the FADD leading to oligomerization of
procaspase-8 [14, 126]. This leads to formation of a massive molecule complex
called DISC (death inducing signal complex). Caspase-8 and caspase-10 both
react with FADD in the ligand-mediated activation of death receptors. They
have different apoptosis substrates and thereby function differently. Dimeriza-
tion of procaspase-8 results in the formation of active caspase-8 and caspase-10.
Caspase-8/10 cleaves the BH3 (Bcl2-homology domain) protein, Bid, resulting
in a truncated version called tBid. This tBid binds to the survival protein, Bcl2.
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This binding releases multidomain pro-apoptotic proteins belonging to the Bax
subclass: Bak and Bax. Bax and Bak oligomerize and facilitate the process of
cell-death by permeabilizing the mitochondrial membrane.
Stress-Mediated Pathway
The second pathway that activates caspases is the stress pathway. Stress signals
include chemicals, UV irradiation, nutritional deprivation and overexpression
of pro-apoptotic proteins such as Bax. Endoplasmic reticulum (ER) stress results
in accumulation of unfolded or malfolded proteins. ER stress may also lead to
perturbation of Ca2+ homeostasis. Stress signals cause oligomerization of pro-
apoptotic proteins, such as Bax and Bak, downstream, as seen in figure 2.11.
These proteins are normally sequestered at the mitochondrial outer membrane
by the survival protein Bcl2, under non-apoptotic conditions.
2.8.3 Convergence and downstream effects of the core apop-
totic pathways
Once Bax and Bak oligomerize, they insert into the mitochondrial membrane
and breach membrane integrity. This results in a net efflux of cytochrome C from
the mitochondria to the cytosol as in figure 2.11. Apaf-1 binds to and hydrolyzes
ATP/dATP to ADP/dADP. Cytosolic cytochrome C binds to Apaf-1 and in-
duces a conformational change in Apaf-1. Cytochrome C binds to Apaf-1 in the
absence of ATP, but the complex is unstable. Cytochrome C and Apaf-1 form a
multimeric complex. This initiates the formation of the apoptosome by Apaf-1-
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Figure 2.11: UPR mediated apoptosis is controlled by the activation of
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other DNA damage inducible products from the mitochon-
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28
mediated recruitment of procapase-9 via homologous CARD motifs, as seen in
figure 2.11. The N-terminal of Apaf-1 and the prodomain of procaspase-9 have
complementary shapes and opposite charges. The apoptosome is a 1MDa hep-
tamer that consists of 7 cytochrome C, 7 Apaf-1 and 7 procapase-9 molecules.
This complex brings the procaspase molecules into close proximity and permits
autocatalysis [235]. The activated caspase-9, in turn, activates procaspase-3 and
procaspase-7. The activated caspase-3 goes back to activate caspase-9. This
forms a positive feedback loop as seen in figure 2.11. Not surprisingly, the mice
deficient in Apaf-1 exhibit a phenotype similar to that of caspase-3-deficient
mice [57, 19]. These mice die soon after birth and exhibit enlarged brains. This
observation, however, does not mean that Apaf-1 is indispensable at the cellu-
lar level. The activated executioner caspases cleave cellular proteins like PARP
[poly (ADP-ribose) polymerase], lamin, fodrin and Bcl2, as in figure 2.11. This
leads to morphological changes in these proteins.
2.8.4 The Calcium Connection with UPR
Recent evidence indicates that there is a crosstalk between the ER and mitochon-
dria during apoptosis, which might initiate mitochondrial apoptotic events [33].
This crosstalk may be facilitated via the release of Ca2+ ions from the ER into
the cytosol, in response to ER stress. Increased cytosolic Ca2+ leads to mitochon-
drial uptake of Ca2+ as in figure 2.13.
IncreasedCa2+ uptake initiates mitochondrial membrane fission and caspase
activation via a mechanism which is yet unknown. The details of ER Ca2+ re-
lease are yet to be elucidated. Ca2+ concentration in the ER determines the cells
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sensitivity to apoptotic stress. Genetic ablation of the ER Ca2+ buffering protein
calreticulin, or overexpression of plasma membrane Ca2+ ATPases protect cell
from apoptosis [128, 153]. Overexpression of SERCA or Calreticulin sensitizes
cells to apoptosis [153, 4]. A few key drivers of the process of ER Ca2+ release
in response to stress signals have been identified. Fas-mediated caspase-8 acti-
vation leads to cleavage of the membrane-bound ER protein, Bap31 . Although
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Bap31 is membrane-bound, its caspase-recognition sequence faces the cytosol,
and therefore is accessible for cleavage by caspase-8. The truncated product,
Bap20, is believed to promote the release of ER Ca2+. Bcl2 is also located on the
ER membrane and the disruption of Bcl2 leads to increased release of ER Ca2+
[38, 190, 33]. It is assumed that ER-based Bcl2 protein is likely to function in a
manner akin to that of mitochondrial Bcl2 [1]. Ca2+ release via inactivation of
Bcl2 also results in the activation of ER-specific caspases-4 and 12. These cas-
pases, in turn, are able to activate the executioner caspases-3, -6 and -7. Bad
is the pro-apoptotic protein that bores holes into the mitochondrial membrane
by self-oligomerization. Interestingly, Bad is regulated by the Ca2+-binding pro-
tein phosphatase, called calcineurin. Calcineurin is activated by binding to ac-
tive calmodulin protein, also a Ca2+-binding protein, and four Ca2+ ions. Under
normal conditions, Bad is kept sequestered in the cytosol by the cytoplasmic an-
chor, 14-3-3sigma. The activity of Bad is inhibited by the addition of a phosphate
group by Akt, a serine-threonine protein kinase. Upon induction of apoptosis,
14-3-3sigma is cleaved by caspase-3, thus releasing Bad. The activity of Bad is
further enhanced by calcineurin-mediated dephosphorylation of the inhibitory
phosphate group (added by Akt). Once active, Bad can translocate to the mito-
chondrial membrane and initiate membrane permeabilization.
Thapsigargin induces the release of Ca2+ from the ER, leading to increase of
cytosolic Ca2+ [170]. This acts as an irreversible inhibitor of SERCA pump [97].
Ca2+ has been shown to modulate the apoptotic signals [132]. The key role of the
Ca2+ which enters the mitochondria is to modulate the permeability transition
(PT) pore (PTP) [8]. PTP has been shown to modulate the apoptotic signals [32].
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2.8.5 Other aspects of apoptosis mediated by stress
IRE1α, ATF6 and PERK are transmembrane protein kinases which play a key
role as ER stress sensors. The oligomerized protein kinases then activate the
p38MAPK and JNK stress pathways and also inhibit the translation factor, eIF2.
These stress pathways can lead to the activation of DNA damage response pro-
teins such as p53. p53 indirectly facilitates caspase activation by enhancing the
transcription of pro-apoptotic proteins such as Bad. Caspase-12 plays a ma-
jor role in apoptosis during stress-mediated UPR. JNK activation occurs using
TRAF2 and ASK1, as in2.6. CHOP mediates in the apoptosis such that over-
expression of CHOP induces cell cycle arrest [86]. Heterodimerization of ATF4
and C/EBP induces the expression of GADD153 [43]. This leads to the control
of various genes including Bcl2 family of proteins. Dimerization of GADD153
and CREB suppresses the expression of Bcl2 [120]. Overall stress induced apop-
tosis occurs through mitochondria-dependant, mitochondria independent, and
caspase-12 pathways.
2.9 Critical role of GRP78 in UPR
Elevated glucose metabolism is seen in Cancer cells along with increased gly-
colytic activity. Tumor cells grow faster than they get blood supply. These con-
ditions lead to a microenvironment that is deprived of glucose and hypoxic. A
direct consequence of this fact is the accumulation of underglycosylated and
incorrectly folded proteins. These lead to the initiation of UPR.
GRP78 belongs to the HSP70 family of proteins. Under normal conditions,
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prevention of BAX mediated apoptosis. So the normal func-
tionality of a stressed cell is altered due to the role of GRP78.
GRP78/BiP resides in the ER. BiP is involved in facilitating proper protein fold-
ing, preventing protein aggregation and targeting proteins for degradation. BiP
also plays a role in binding ER Ca2+, thereby acting as an ER stress regulator
[101, 68]. Normally it is attached to ER stress transducers and, on initiation of
UPR, is detached from the transducers.
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Higher amounts of BiP is seen to be expressed in tumors [106, 39]. It has also
been seen that BiP is detected on the surface of highly metastatic prostate cancer
cells [125]. Higher production of BiP prevents the formation of misfolded pro-
teins. Due to binding of the BiP to Ca2+, it preserves ER Ca2+ homeostasis. Some
amount of BiP is also located on the ER membrane [160]. ER membrane localiza-
tion could lead to binding and inhibition of caspase-7. This prevents apoptosis
induced by ER stress and genotoxic drugs [105, 160, 29]. This also leads to re-
sistance to chemotherapeutic agents, as noted in lung, bladder, stomach, breast
tumors and epidermoid carcinoma [105]. BiP also binds and prevents activation
of BIK, which prevents the activation of BAX [157, 47]. This prevents release of
cytochrome C from the mitochondria, thus preventing apoptosis.
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CHAPTER 3
MODEL FORMULATION AND MODEL ANALYSIS OF UNFOLDED
PROTEIN RESPONSE
3.1 Materials and Methods
The interactions of the proteins in Unfolded Protein Response, were modeled
using a set of differential equations. This model was solved deterministically to
obtain concentration profiles of proteins. These profiles were compared to the
experimental observations found in the literature.
Once we obtained a qualitatively correct representation of the system, we
studied the robustness of the system using sensitivity analysis and coupling
studies. This cycle of model formulation and analysis presents provides the op-
portunity improve the model in every trial. This full circle approach has been
shown to work in other studies in the Varner lab. The mathematical tools em-
ployed in the formulation and analysis of this model is presented in the current
chapter.
3.1.1 Formulation and solution of the model equations
The unfolded protein response model was formulated as a set of coupled Ordi-
nary Differential Equations (ODEs):
dx
dt
= S · r (x,p) x (to) = xo (3.1)
The symbol S denotes the stoichiometric matrix (521 × 964). The quantity x de-
notes the concentration vector of proteins or protein complexes (521 × 1). The
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term r (x,p) denotes the vector of reaction rates (964 × 1). Each row in S de-
scribed a protein while each column described the stoichiometry of network
interactions. Thus, the (i, j) element of S, denoted by σi j, described how protein
i was involved in rate j. If σi j < 0, then protein i was consumed in r j. Con-
versely, if σi j > 0, protein i was produced by r j. Lastly, if σi j = 0, there was no
protein i in rate j. All of these interactions were obtained from the literature.
We assumed mass-action kinetics for each interaction in the network. The
rate expression for protein-protein interaction or catalytic reaction q:∑
j∈{Rq}
σ jqx j →
∑
p∈{Pq}
σpqxp (3.2)
was given by:
rq
(
x, kq
)
= kq
∏
j∈{Rq}
xσ jqj (3.3)
The set
{
Rq
}
denotes reactants for reaction q. The quantity
{
Pq
}
denotes the set
of products for reaction q. The kq term denotes the rate constant governing the
qth interaction. Lastly, σ jq, σpq denote stoichiometric coefficients (elements of
the matrix S). We treated every interaction in the model as non-negative. All re-
versible interactions were split into two irreversible steps. The mass-action for-
mulation, while expanding the dimension of the initiation model, regularized
the mathematical structure. The regular structure allowed automatic genera-
tion of the model equations. In addition, an analytical Jacobian (A) and matrix
of partial derivatives of the mass balances with respect to the model parameters
(B) were also generated. Mass-action kinetics also regularized the model param-
eters. Unknown model parameters were one of only three types, association,
dissociation or catalytic rate constants. Thus, although mass-action kinetics in-
creased the number of parameters and species, they reduced the complexity of
model analysis. In this study intracellular concentration gradients of the pro-
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teins is simplified as having different species for each compartment. All these
equations are solved using the LSODE routine in OCTAVE (v 2.9) on Apple ma-
chines.
3.1.2 Creation of the ensemble of models
Once the basic architecture of the model was set, it was important to obtain the
rate constants (964 unknowns) for the interactions. These rate constants were
not available in the literature. So the initial formulation of the model, involved
the guessing of the rate constants and further improving of the guess based on
literature data. These self-improving iterations were carried out untill we got
the best resemblance to the data available.
Eight experimental constraints were used to formulate the rate constants of
the model along with the understanding of the remaining network as seen in the
literature. These experimental constraints are in fact western blot data of certain
proteins in the UPR pathway measured at certain time points. The western
blot data is quantified using GelEval 1.22 (FrogDance Software). GelEval allows
us to measure the densities of the gel bands. To reduce inconsistency in the
reading, multiple readings were obtained for the mean and standard deviation.
A tabulation of the measured data along with the specific species are presented
in tables 3.1-3.8.
These measurements give us a measure of the density of the bands. Owing to
the differences in the protocol undertaken by different labs, different blots could
have different implications. So the key here is to treat the data so as to normalize
them to obtain some consistency in the data. This we do by normalizing the
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Table 3.1: Geleval measurements of BiP Wester blots [9]
Time (mins) Avg. Intensity ± Std. Dev.
0 0.4035 ± 0.1737
10 0.3280 ± 0.1778
20 0.14 ± 0.0445
Table 3.2: Geleval measurements of Caspase 3 Western blots [159]
Time (hrs) Avg. Intensity ± Std. Dev.
0 0.2795 ± 0.0007
12 0.2670 ± 0.0005
24 0.2570 ± 0.0028
36 0.3135 ± 0.0134
Table 3.3: Geleval measurements of Caspase 7 Western blots [159]
Time (hrs) Avg. Intensity ± Std. Dev.
0 0.3 ± 0.0001
12 0.29 ± 0.0014
24 0.3503 ± 0.0021
36 0.2385 ± 0.0021
Table 3.4: Geleval measurements of Cleaved Parp Western blots [159]
Time (hrs) Avg. Intensity ± Std. Dev.
0 0.28 ± 0.0042
12 0.31 ± 0.0056
24 0.5255 ± 0.0091
36 0.6155 ± 0.0275
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Table 3.5: Geleval measurements of PERK Western blots [9]
Time (mins) Avg. Intensity ± Std. Dev.
0 0.811 ± 0.0791
10 0.6085 ± 0.1350
20 0.056 ± 0.0028
Table 3.6: Geleval measurements of Phosphorylated PERK Western blots
[9]
Time (mins) Avg. Intensity ± Std. Dev.
0 0.064 ± 0.0028
10 0.6385 ± 0.0813
20 0.835 ± 0.0565
Table 3.7: Geleval measurements of Pro-caspase 7 Western blots [159]
Time (hrs) Avg. Intensity ± Std. Dev.
0 0.571 ± 0.0353
12 0.446 ± 0.0155
24 0.325 ± 0.0155
Table 3.8: Geleval measurements of Pro-caspase 12 Western blots [159]
Time (hrs) Avg. Intensity ± Std. Dev.
0 0.551 ± 0.0098
12 0.4125 ± 0.0035
24 0.235 ± 0.0020
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above mentioned data presented in tables 3.1-3.8.
Say we have the experimental data for species xi for time {t1, t2, .., tn} as:
exi = {exi,t1 , exi,t2 , ..., exi,tn} (3.4)
Given this set of data we normalize the data as:
ˆexi =
exi,t1 − min{exi}
max{exi} − min{exi} (3.5)
This normalizing is done with every data set to obtain consistency. Once
we have the normalized data, the next step is to obtain a best parameter set by
hand. Initially a best guess estimate of the parameters is done by hand fitting
so as to obtain the best set of parameters which we shall call as the nominal set.
In order to compare the result with the experimental values, we pick out the
simulation values for the species xi for the entire time period {t1, ...., tn} as:
sxi = {sxi,t1 , sxi,t2 , ..., sxi,tn} (3.6)
We normalize the simulation data in the same scheme as 3.5 to maintain
consistency.
ˆsxi =
sxi,t1 − min{sxi}
max{sxi} − min{sxi} (3.7)
Scaling the simulation results similar to the experimental results, allows us
to compare the qualitative profiles of the proteins. The basic idea behind this
approach is to consider the western blots as representative of a function limiting
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its values to 0 and 1. So the darkest plot is equal to 1 and the lightest blot is equal
to 0.
Once we have obtained the best possible nominal set, the question arises
whether this is the best possible representation of the system of equations in-
volved in UPR. There could be multiple combinations of rate constants that
could represent the system qualitatively. This problem is pertinent to such a
system, owing to the larger number of unknowns and limited number of con-
straints. This issue was addressed by formulating a family of models, that be-
have qualitatively similar to the nominal model set. The family of models was
generated using the Multi-Objective thermal annealing scheme.
3.2 Multi-Objective Simulated Annealing Scheme
After obtaining the nominal set of parameters, the search of ensemble of param-
eters posed a challenge. Several uses of multi-objective schemes have been used
in literature [184, 147]. These schemes use Pareto-Fronts to dictate selection of
ensemble of parameters.
We treat the data set of each protein as one objective function. As a result,
the eight objective functions we formulate, form the objective function space,
wherein we are looking for the global minimum. The objective functions were
defined as minimizing the error between the current evaluation of the simu-
lation with the native set of parameters and the experimental results obtained
from the literature. So the error or the ith objective function value is formulated
as:
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errori =
∑
t
{ ˆsxi,t − ˆexi,t
0.5 ∗ ˆexi,t }
2 (3.8)
The aim of the optimization scheme is to minimize errori as stated in equa-
tion 3.8. Any optimization scheme to be used to minimize an 8-dimensional ob-
jective space, must address the trade-off between each objective function. Using
the concept of Pareto-Fronts based optimization targets this issue justly. The
concept of Pareto-Fronts combined with Simulated Annealing presents a suit-
able scheme, to obtain an ensemble of parameters.
Getting into the depth of the scheme, the energy function E(x) is defined as
the scalar measure of errori. Imposing the condition of Pareto-Fronts, we obtain
certain optimum solutions which are a set of non-dominant solutions. These op-
timum solutions are a trade-off of the multiple objective functions. On the other
hand, a single objective minimization scheme uses one objective function, using
all the errors. In this type of algorithm, we do not have the option to control the
errors in each data point. In our system, it is imperative to give weighted im-
portance to all the objective functions. Pareto-Front based optimization schemes
allows simultaneous minimization of all the objective functions.
In our model, a Pareto-optimal based energy function is used which uses the
rank-based fitness assignment [44]. If we have kVi as the the solution (set of rate
constants) and it is dominated by p members, then based on the archive of the
solutions the rank of the current solution is given by
rank(kVi|Farchive) = p (3.9)
In simple sense the rank of the solution is equal to the number of solutions
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that are dominating it. This dominance is measured based on the values of
the objective values. So the basic non-dominant solutions are ranked ′0′. The
acceptance probability of the solution kVi is based on the rank value,
Paccept(kVi) = exp−rank(kVi|Farchive)/T (3.10)
Here T is the computational annealing temperature. So the solutions with
higher energy have a chance of being accepted only at higher temperatures.
Accordingly at lower temperatures, the solutions come closer to a global mini-
mum. The algorithm is outlined in table 3.9.
The updating scheme of the parameters include, generating a new parameter
set based on randomly perturbing the parameters by upto ±50. The solution is
now accepted based on the probability as stated in equation 3.10.
So the key features of this algorithm are: the initial temperature, the anneal-
ing scheme and the perturbation method. The effect of the initial temperature
was tested and finally we settled with the temperature as dependent on n, which
is equal to the dimension of the objective space. So the initial temperature is set
as n/log(2). This allows initially half of the proposals with rank value n to be
accepted. This also means that initially parameters with rank less than n have a
higher probability than of being accepted. In our case the value of n is 8, as we
are using 8 objective functions or in other words 8 experimental sets to match
our data.
Now according to the annealing scheme, the temperature is adjusted as we
are coming close to the global minimum. The temperature is updated according
to Tk = βkTo. Here β is chosen based on the final temperature and the epoch k is
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Table 3.9: Algorithm for Multi-objective Thermal Annealing
kV : parameter vector
C(kV) : multi-objective cost function vector
(C(kV) = (error1(kV), error2(kV), ..., error8(kV)))
F : an archive of the current estimate of the ensemble
R(C(kV)|F) : a Pareto-optimal rank based dominance
measure
kV = kVinit : the starting point of parameters
T = T0 : initial annealing temperature
Repeat
kVnew = perturb (kVold)
Generate the new parameter set by randomly perturb-
ing the previous parameter set
Calculate C(kVnew) and R(C(kVknew)|F)
Paccept(kVnew, kVold) ≡ exp{−R(C(kVnew)|F)/T }
if Paccept(kVnew, kVold) > rand(0,1)
Move to kVnew
Update the archive F
endif
T = annealing(T)
EndRepeat(Until the termination condition is satisfied)
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updated every 100 iterations as (k = 1, ..., 10).
The third key feature of the algorithm is the perturbation scheme. There are
certain options in the way we perturb the parameters. It is possible to perturb
parameters one at a time, but this proves to be computationally very expensive.
On the contrary, the other possibility is to perturb all the parameters together.
This poses the requirement of a long time to find an acceptable solution. This
is the scheme that has been used in perturbing the rate constants in our model.
A better methodology which can be employed in the future models is to divide
the parameters into subgroups and use weighted perturbation schemes.
Once we obtained a family of parameters, we study the robustness of the
system, using sensitivity analysis and coupling studies.
3.2.1 Sensitivity analysis of the UPR network
Overall State Sensitivity Coefficients (OSSC) were used to estimate which struc-
tural elements of the UPR network were sensitive [185]. OSSC values were de-
termined by first calculating the first-order sensitivity coefficients at time tk:
si j (tk) =
∂xi
∂p j
∣∣∣∣∣∣
tk
(3.11)
First-order sensitivity coefficients were computed by solving the matrix differ-
ential equation:
ds j
dt
= A (t) s j + b j (t) j = 1, 2, . . . , P (3.12)
subject to the initial condition s j(t0) = 0. In equation 3.12, j denotes the param-
eter index, P denotes the number of parameters in the model, A denotes the
Jacobian matrix, and b j denotes the jth column of the matrix of first-derivatives
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of the mass balances with respect to the parameter values (denoted by B). An
analytical Jacobian and matrix of first-derivatives of the mass balances w.r.t the
parameters:
A =
∂fx
∂x
∣∣∣∣∣∣
(x∗,p∗)
B =
∂fx
∂p
∣∣∣∣∣∣
(x∗,p∗)
(3.13)
were generated from the model equations. The quantity fx = S · r (x,p) and
(x∗,p∗) denotes a point along the unperturbed model solution. The sensitivity
equations required that we solve the model equations to evaluate the A and B
matrices. Thus, we formulated the sensitivity problem as an extended kinetic-
sensitivity system of equations [37]: x˙s˙ j
 =
 S · r (x,p)A (t) s j + b j (t)
 j = 1, 2, . . . , P (3.14)
where x˙ = dx/dt and s˙ j = ds j/dt. We solved the kinetic-sensitivity system for
multiple parameters in a single calculation using the LSODE routine of OC-
TAVE (www.octave.org). The first-order sensitivity coefficients were then used
to calculate the OSSC value for parameter j:
OSSC j (t) =
p j
Ns
( NT∑
k=1
Ns∑
i=1
[
1
xi
∂xi
∂p j
∣∣∣∣∣∣
tk
]2)1/2
(3.15)
The terms NT , Ns denote the number of time points considered and the state
dimension of the model, respectively. This sensitivity was calculated on the
nominal set. The scaled parameter ranking was calculated based upon the mag-
nitude of the OSSC value:
θs j =
NP − Rs j
NP
(3.16)
NP denotes the number of kinetic parameters and Rs j denotes the ranking of
parameter j calculated using parameter set s. We estimated the fragility of each
protein or protein-complex in the network according to the relationship:
Fs = |S|Θs (3.17)
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|S| denotes the absolute value of the stoichiometric matrix. Θs denotes the vector
of scaled parameter rankings calculated using parameter set s.
Another methodology employed in the calculation of the sensitivities was by
normalizing the sensitivity coefficients using the nominal parameter and state
values:
Ni j = si j(tk)
p j
xi
(3.18)
The normalized sensitivities are then time-averaged by integration using
Simpson’s rule:
NSS i j ≡ 1T
∫ T
0
dt · |Ni j(t)| (3.19)
The normalized sensitivities NSS i j can be interpreted as the approximate
fractional change of the state variables xi for a small change in the parameter p j.
This sensitivity values were analyzed using the method of Hearne to estimate
the best combination of parameters to obtain the best result.
3.2.2 Monte-carlo coupling analysis of the UPR architecture.
Coupling coefficients of the form:
α
(
i, j, to, t f
)
=
(∫ t f
to
xi (t) dt
)−1 (∫ t f
to
x( j)i (t) dt
)
(3.20)
were calculated to understand the robustness of the UPR network. Here t0 and
t f denote the initial and final simulation time respectively. i and j denote the
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indices for the reference species and the perturbed species respectively. The
coupling coefficient α
(
i, j, to, t f
)
is the ratio of the integrated concentration of
a network output in the presence (numerator) and absence (denominator) of
structural or operational perturbation. If α
(
i, j, to, t f
)
> 1, then the perturbation
increases the output concentration. Conversely, if α
(
i, j, to, t f
)
 1 the perturba-
tion decreases the output concentration. Lastly, if α
(
i, j, to, t f
)
∼ 1 the perturbation
does not influence the output concentration. In this study, we simulated edge
coupling which induces the removal of a particular reaction to understand the
change of all the protein concentrations based on the reaction removal. This
scheme also has inbuilt the option to do protein knockouts.
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CHAPTER 4
RESULTS AND DISCUSSION
The primary approach employed in this study, is to mimic a complex biolog-
ical system by constructing an equivalent mathematical model. We have used
the ’system of systems’ approach, to model the UPR machinery of the cell. The
fully functional model describe, qualitatively, the trends observed for some of
the species (proteins) in literature. It is not just the model but even the tools that
was used to generate this model, that is of interest in this study.
4.1 Parameter ensemble creation results
Multi-objective thermal annealing scheme was used to generate the parameter
sets as stated in table 3.9. There could be many developed strategies for selection
and perturbation of the parameters. Owing to the complexity of the system, we
purturbed all the parameters simultaneously.
The scheme for perturbation employed in this study is:
kVnew = kVold ∗ (1 + (2 ∗ rand(N, 1) − 1) ∗G) (4.1)
Here N is the number of unknown rate constants (964). G is a constant which
determines the maximum and minimum variation of the rate constants (G=0.5
denotes ± 50% variation of the rate constants). This perturbation scheme, is
employed into the multi-objective Pareto-Frontiers algorithm stated in table 3.9.
Every perturbation is accepted provided they meet two conditions:
Criterion 1: They have met the rank criterion Rank(kVnew) ≤ 2
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Figure 4.1: Low Diversity search of the parameter space: This enables us
to obtain parameters sets that best describe the local minimum
around the nominal set. The perturbation scheme involves per-
turbing the nominal set every time.
Criterion 2: Maximum value of the objective value should be less than three
times the objective value of the nominal set. Lower limit of the objective value
gives a lower acceptance rate of parameters and vice versa for higher limits.
Besides the perturbation scheme and the acceptance criterion, the search of
the parameter space is also significant. To target this issue, two different search-
ing strategies were used. The first approach was meant to search the parameter
space around the nominal set as in figure 4.1. This is representative of the local
minimum in the parameter space.
We represent the ensemble of parameters as EOP and the individual ele-
ments as EOPi. The plot of the Coefficient of Variation (CV) of the EOP for the
low diversity case is show in figure 4.2. CV is measured as the ratio of the stan-
dard deviation to the mean. This gives an idea of the normalized measure of
dispersion of EOP. In the low diversity case the CV values ranges from 0.273-
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Figure 4.2: CV plot of the low diversity ensemble of parameters: This plot
is representative of the low diversity of the ensemble with the
CV centered around 0.29.
0.305. These values represent the lack of diversity in the parameters. It can also
be seen as representing the local minima in and around the nominal parameter
set.
The spread of the ensemble around the parameter space can be studied using
the 2nd norm of the EOPi. The histogram of the 2nd norm values is plotted in
4.3. This shows a clear bell shaped curve centered around 0.3. The standard
deviation of the distribution is the required spread parameter.
This kind of study, as just described, does not encapture the possible high
diversity in the parameters. We utilize a different approach to address this
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Figure 4.3: Histogram of the 2nd norm of the low diversity ensemble of
parameters: This shows how the ensemble of parameters is
spread around a mean CV of 0.29.
drawback. In this modified approach, each perturbation was based on the pre-
vious accepted perturbation. The perturbation scheme and the acceptance cri-
terion was similar to the low diversity ensemble creation scheme. This scheme
is shown in the figure 4.4.
In this case we moved around a great deal in the parameter space. This is
represented by the cv plot and the histogram plots.
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Figure 4.4: High Diversity search of the parameter space: This strategy is
targeted to obtain diverse parameter sets well beyond the local
minimum of the nominal set. This search strategy could indeed
lead us to the global minimum of the parameter space. In this
scheme every perturbation of the parameters is based on the
previous accepted perturbation.
In comparison to the low diversity case we see that in the high diversity case
we have higer CV (in the range of 10). To compare the diversity of the ensemble
of parameters we look of the 2nd norm of the values as in figure 4.6. The values
of the 2nd norm range from 0 − 146 in the high diversity case, in comparison to
0 − 0.35 for the case of low diversity ensemble. This ensures that the spread of
the parameters from the nominal set is quite diverse. Having ensured that we
have the correct strategy employed in searching the parameter space we look
into how the model is behaving.
The scheme employed to search the parameter space along with the opti-
mizing scheme of pareto frontiers is in contrast to the approach where a single
objective function is optimized. We have classifed the experimental data into 8
objective funcitions. The optimizing scheme finds a trade-off to reach the global
minima in the parameter space. We took a look at the evaluations of these ob-
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Figure 4.5: CV plot of the high diversity ensemble of parameters: This plot
shows the high diversity of the parameter sets obtained as com-
pared to the low CV of 0.29 obtained in the low-diversity case.
jective values to see how well the fronts were formed. This gives an idea as to
which parameter set is more important than the other.
In figure 4.7 and 4.8, the objective values are evaluated for the all the pa-
rameter sets and plotted against each other. For the low diversity case as in
figure 4.7 we see that (top left part of the quadrant) the objective values are not
well constrained. This suggests that these functions were not the controlling
functions during parameter search. On the contrary we see well defined pareto
fronts on the lower right quadrant. This tells us that objective function 6 and
7 are of prime importance for parameter selection. The approach of having a
tradeoff in terms of objective values for multiple objective functions is clearly
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Figure 4.6: Histogram of the 2nd norm of the high diversity ensemble of
parameters: This shows the wide range of CV of the parameter
space that is explored. In this scheme, we see that we have
reached a global minimum centered around the CV of 1.
demonstrated in the figure 4.7.
When we look at the high diversity case in figure 4.8, we find well defined
pareto fronts on the lower part of the figure. This observation is consistent in
saying that objective function 6, 7 and 8 are of prime importance. This corre-
sponds to the tradeoff between the error values of Caspase 3, Caspase 7 and
Cleaved Parp. One interesting thing to note that there are two parrallel fronts
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Figure 4.7: Combined grid of objective value plot for the Low diversity:
This is a combination of 2-dimensional plots of each objective
function with the other. The black dot in each of the plots indi-
cate the objective value of the nominal set. We find that some
objective functions are tightly constrained, like objective func-
tions 6,7. The scheme has been successful in obtaining a trade-
off between these functions, as shown in the lower right quad-
rant. Other objective functions do not have that much variation
over the parameter space that has been explored. So we have
some scattered plots towards the upper left quadrant of the fig-
ure.
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being created in the top left corner. This could denote bifurcation in the system.
It could also imply the presence of two local minimas in the parameter space
which have the same objective function evaluations. This area of the model is
yet to be studied. This kind of study could be used to identify the significant
objective functions and to improve optimization techniques.
4.2 Model Validation
Once we obtained the parameter sets using both the schemes, we look at how
the model is behaving with respect to the training and prediction sets. The
choice of the training and prediction sets was purely at random. Some upstream
and some downstream data sets were selected at random and divided into two
groups. One group was used for training the data and the other to test the
predictions of the model.
The interaction of BiP with PERK and IRE1 has been studied [9]. The au-
thors stated that ER stress induced by Thapsigargin (Tg) leads to the dissocia-
tion of the BiP-PERK complex. This study was conducted in AR42J cells. These
cells were treated with Tg or dithiothreitol (DTT) for certain time periods. The
treated cells were then immunoprecipitated with the corresponding antisera.
The individual components were then resolved by SDS-PAGE. This set of data
is used for training the model. The performance of the model with respect to
this data is shown in figure 4.9.
In another study, Sak2 cells were treated with 0.5 µM thapsigargin to induce
ER stress [159]. Cytosolic extracts from these cells were extracted and analyzed
by western blots. Caspase-12, caspase-9, caspase-7, caspase-3 and PARP were
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Figure 4.8: Combined objective plot for the high diversity: This is a com-
bination of 2-dimensional plots of each objective function with
the other. We find that some objective functions are tightly
constrained, like objective functions 6,7. The scheme has been
successful in obtaining a tradeoff between these functions, as
shown in the lower right quadrant. On the contrary we find
multiple fronts towards the upper left quadrant. These fronts
could be representative of bifurcation in the system. It could
also be representation of local minima in the parameter space.
This are of the model is yet unexplored in the study.
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Figure 4.9: Plot of model output against training data for the low diversity
case. Simulation results are plotted as the grey bar graphs with
one standard deviation as the error bar. Experimental data
taken from [9]. In the experiments AR42J cells were treated
with thapsigargin (Tg) or dithiothreitol (DTT) for the indicated
time periods, and immunoprecipitated with the indicated anti-
sera. (a) Upon UPR induction BiP is seen to vary consistently to
the experimental data (b) Shows the trends observed for PERK
upon UPR induction (c) Phosphorylated PERK profile upon
UPR induction. We see that the right trend is followed in the
model as seen in the data.
60
0 12 24 36
0
0.2
0.4
0.6
0.8
1
Sc
al
ed
 C
on
ce
nt
ra
tio
n 
(0
-1
)
(c)
0 12 24
0
0.2
0.4
0.6
0.8
1
Sc
al
ed
 C
on
ce
nt
ra
tio
n 
(0
-1
)
(d)
0
0.2
0.4
0.6
0.8
1
Sc
al
ed
 C
on
ce
nt
ra
tio
n 
(0
-1
)
(a)
0 12 24 36
0
0.2
0.4
0.6
0.8
1
Sc
al
ed
 C
on
ce
nt
ra
tio
n 
(0
-1
)
(b)
0 12 24 36
Time in hrs
Time in hrs
Time in hrs
Time in hrs
Caspase 7 Cleaved Parp
Procaspase 7 Procaspase 12
Figure 4.10: Plot of model output against training data for the low diver-
sity case. Simulation results are plotted as the grey bar graphs
with one standard deviation as the error bar. Experimental
data taken from [159]. In this experiment Sak2 cells were
treated with 0.5 µM thapsigargin for the indicated times. Cell-
free cytosolic extracts from thapsigargin treated cells were
prepared and analyzed by Western blot analysis. (a) Cas-
pase 7 profile (b) Cleaved Parp profile (c) Procaspase 7 profile
(d) Procaspase 12 profile upon UPR induction is shown. We
see that the model is behaving consistent to the experimental
data.
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some of the key components that were studied. Some of the data presented in
this study were used as the training sets for our UPR model. Low diversity
ensemble, shows clearly to be following the trends as seen in the experimental
observation.
Similarly we look at the performance of the model with the high diversity in
the parameters as in figure 4.11.
We see that qualitatively similar results and closeness to training data for
both the low and the high diversity ensemble of parameters. Again, the aim
is to mimic the real system observations. As an additional note, increasing the
number of data sets for training will further constrain the system. This could
provide further improvement in the model performance.
4.3 Model Predictions
Having seen that the model behaves correctly according to the training data
sets, it now remains to see how well the model predicts the species that it has
not been trained for. This ability of the model was tested for a few species across
different stages of the pathway with some other western blots data available in
the literature.
In one study [64], MEF’s were treated with Thapsigargin (Tg, 0.4 µ M). Im-
munoblots of the ATF4 from the nuclear fractions were compared to the simu-
lation results. The high diversity and the low diversity models makes correct
predictions for the formation of ATF4 upon UPR induction as seen in figure
4.12(a) and 4.13(a).
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Figure 4.11: Plot of model output against training data for the high diver-
sity case. Simulation results are plotted as the grey bar graphs
with one standard deviation as the error bar. Experimental
data taken from [9, 159]. (a) and (c) Data taken from [9]. In
the experiments AR42J cells were treated with thapsigargin
(Tg) for the indicated time periods, and immunoprecipitated
with the indicated antisera. Profile of BiP and phosphorylated
PERK are shown as matching the experimental data. (b) Data
taken from [159]. In this experiment Sak2 cells were treated
with 0.5 µM thapsigargin for the indicated times. Cell-free cy-
tosolic extracts from thapsigargin treated cells were prepared
and analyzed by Western blot analysis. Comparison of Cas-
pase 3 profile upon UPR induction is shown with respect to
the experimental evidence.
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Figure 4.12: Plot of model output against prediction data for the Low di-
versity case. Simulation results are plotted as the grey bar
graphs with one standard deviation as the error bar. Experi-
mental data taken from [64, 159, 204]. (a) Data obtained from
[64]. Immunoblots of ATF4 from the nucleur fraction of the
untreated and thapsigargin-treated (Tg, 0.4µM) in mouse fi-
broblasts are compared to the simulation data. (b) and (c)
Data obtained from [159]. Cell-free cytosolic extracts from
thapsigargin treated Sak2 cells, treated with 0.5 µM thapsi-
gargin are analyzed. In (b) the western blot of Whole PARP is
compared with the simulation result. In (c) the western blot of
Procaspase 3 is compared with the simulation result. (d) Data
taken from [204]. Phosphorylation of eIF2α, in wild type (S/S)
MEF cells, treated with 1.0 µM Tg is compared with the simu-
lation results of our model. We show consistent performance
of the model, according to the experimental observations.
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Figure 4.13: Plot of model output against prediction data for the high di-
versity case. Simulation results are plotted as the grey bar
graphs with one standard deviation as the error bar. Ex-
perimental data taken from [64, 183, 159, 204]. (a) Data ob-
tained from [64]. Immunoblots of ATF4 from the nucleur frac-
tion of the untreated and thapsigargin-treated (Tg, 0.4µM) in
mouse fibroblasts are compared to the simulation data. (b)
Data obtained from [183]. Western blot of cleaved ATF6 in
tunicamycin-treated HeLa cells is compared with the simu-
lation result. (c) Data obtained from [159]. Western blots of
Caspase 12 in Sak2 cells, treated with 0.5 µM thapsigargin
is compared with the simulation result. (d) Data taken from
[204]. Phosphorylation of eIF2α, in wild type (S/S) MEF cells,
treated with 1.0 µM Tg is compared with the simulation re-
sults of our model. We see consistent predictions of the the
species from the model at hand.
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In [159] Sak2 cells were treated with 0.5 µM thapsigargin for certain time pe-
riods. Cell-free cytosolic extracts from thapsigargin treated cells were prepared
and analyzed by Western blot analysis. We compared the simulation results of
Procaspase 3 and whole PARP to the western blot data presented in this pa-
per. We found that the model is representing the correct trend as seen from the
experimental results, shown in figure 4.12(b) and (c).
In [204], wild type (S/S) MEF cells were treated with 1.0 µM Tg for the indi-
cated number of hours. Phosphorylation of eIF2αwas measured by immuniblot
by using Ab that specifically recognizes eIF2α phosphorylated at Ser-51. This
result is compared with the simulation results of our model. We see consistent
correct predictions in high and low diversity ensembles, as seen in figure 4.12(d)
and 4.13(d).
The model as a whole, is behaving in the correct manner as seen by the pre-
diction sets. We can employ more data sets to test this system. Now that we are
convinced that the model work, we go on to test the fragility of the system.
4.4 Sensitivity Analysis of the UPR Model
Once we obtained the fully functional model which match the training data, we
look into the fragility of the system. Sensitivity analysis reveals the fragile com-
ponents of the system. Given the constraint of computational effort involved,
the sensitivity calculations have been run on the system with and without UPR
induction for the nominal set of parameters only.
In figure 4.14 we see the plot of the OSSC values for the UPR model. In fig-
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ure 4.14(a) we have the plot of the OSSC values with UPR induction. In figure
4.14(b) we have the OSSC values without UPR induction. We find that the same
species are consistently sensitive, with and without UPR induction. This idea is
presented in figure 4.14(c). The x axis denotes the OSSC values with UPR induc-
tion and the y axis without UPR induction. It is amply clear that the sensitive
species are not preferentially sensitive upon UPR activation.
Due to the large number of species in the plot, we do not get a clearer idea
of the important species. So we subdivided the system to its key components:
UPR initiation, ERAD, apoptosis and translational machinery of the proteins.
We took a deeper look into these subdivisions of the model. Breaking up of the
ATF6-BiP complex is seen to be the most sensitive step in the UPR initiation part
of UPR. Similarly the cleavage of the BiP and ER stress transducers complexes
have high OSSC’s. The binding of the unfolded protein to the chaperone HSP40
is also relatively important as seen in figure 4.15(a). In the apoptotis group of
reactions of the model, we find that increased translation of BiP is of prime
importance, along with the nuclear migration of AIF as seen in figure 4.15(b).
Translation of chaperones and the ER stress transducers are in general more
sensitive as seen in figure 4.15(c). In the ERAD component of the UPR network,
activation of the Ubiquitin by reacting with ATP is seen to be the most sensitive
reaction as seen in figure 4.15(d).
Another alternate approach was used to calculate the sensitivities, as dis-
cussed in the chapter 3.2.1. Once we have the NSS values, we go on further to
rank these parameters. We carry out the singular value decomposition of the
NSS matrix. The V matrix obtained thereby, contains the basis vector direction
of the NSS matrix. We sort these parameters and rank them in a scale of 1-100.
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Figure 4.14: Plot of the OSSC for the UPR model. (a) This plot shows the
OSSC values with UPR induction. (b) This plot shows the
OSSC values with no UPR induction (c) Combined plot of the
OSSC values with UPR induction on the X axis and without
UPR induction in the Y axis. These plots show the highly frag-
ile components of the model and also show that these compo-
nents remain fragile in the stressed and the unstressed cell.
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Figure 4.15: Modular plot of the UPR model: (a) Breaking of the ER stress
transducers and BiP complex are relatively the most fragile
part of the UPR branches. (b) In the apoptosis module, break-
ing up of the homo-dimer of ATF4 is seen to be the most sen-
sitive reaction. Increase in the amount of BiP being produced
is rightly seen as a highly sensitive reaction. (c) In the transla-
tion module of the network, the translation of HSP40, which is
required to sense the unfolded protein, is of high importance
closely followed by PERK, IRE1, eIF2α and BiP translation.
(d) In the ERAD component of the model, it is seen that the
presence of ATP and the reaction of the same with Ubiquitin
is the key step.
69
020
40
60
80
100
0 100 200 300 400 500 600 700 800 900
N
S
S
 r
a
n
ki
n
g
 v
a
lu
e
s 
w
ith
 U
P
R
 in
d
u
ct
io
n
Parameter Index
0
20
40
60
80
100
0 100 200 300 400 500 600 700 800 900
N
S
S
 r
a
n
k
in
g
 v
a
lu
e
s
 w
it
h
o
u
t 
U
P
R
 i
n
d
u
c
ti
o
n
Parameter Index
Figure 4.16: Plot of the NSS value ranking for the UPR model. (a) This
plot shows the NSS ranking for the parameters with UPR in-
duction. (b) This plot shows the NSS ranking with no UPR
induction. These plots show the highly fragile components of
the model and also show that these components remain frag-
ile in the stressed and the unstressed cell. Similar results are
also seen by using the OSSC scheme of sensitivity analysis.
These ranked parameters are shown in the figure 4.16. The output is consistent
with the OSSC results.
It is seen that both the methodologies give the same results, in terms of de-
marcating the most sensitive parameters. These highly sensitive parameters can
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Table 4.1: Highly sensitive reactions as clustered by the k-means algorithm
Rn. ID Reaction OSSC with UPR OSSC without UPR
5 PERK+BiP→ PERK BiP 15.077 9.2714
27 IRE1 TITPKE BiP→ IRE1 TITPKE+BiP 18.092 11.1256
93 []→ ATP 22.615 13.9070
112 []→mRNA BiP 15.077 9.2714
113 mRNA BiP+Ribosome→ Rm BiP 15.077 9.2714
114 Rm BiP→mRNA BiP+Ribosome 15.077 9.2714
116 Rm BiP→ Ar BiP 15.077 9.2714
117 Ar BiP→ BiP+Ribosome 15.077 9.2714
118 []→mRNA HSP 40 30.153 18.5427
119 mRNA HSP 40+Ribosome→ Rm HSP 40 30.153 18.5427
121 Rm HSP 40→ Ar HSP 40 30.153 18.5427
122 Ar HSP 40→ HSP 40+Ribosome 30.153 18.5427
128 []→mRNA PERK 15.077 9.2714
129 mRNA PERK+Ribosome→ Rm PERK 15.077 9.2714
131 Rm PERK→ Ar PERK 15.077 9.2714
132 Ar PERK→ PERK+Ribosome 15.077 9.2714
133 []→mRNA eIF2a 15.077 9.2714
134 mRNA eIF2a+Ribosome→ Rm eIF2a 15.077 9.2714
136 Rm eIF2a→ Ar eIF2a 15.077 9.2714
137 Ar eIF2a→ eIF2a+Ribosome 15.077 9.2714
163 []→mRNA IRE1 TITPKE 15.077 9.2714
164 mRNA IRE1 TITPKE+Ribosome→ Rm IRE1 TITPKE 15.077 9.2714
166 Rm IRE1 TITPKE→ Ar IRE1 TITPKE 15.077 9.2714
167 Ar IRE1 TITPKE→ IRE1 TITPKE+Ribosome 15.077 9.2714
250 []→ Ribosome 15.077 9.2714
378 Bcl2+Bak→ Bcl2 Bak 15.077 9.2714
be further clustered using k-means clustering, to find the most sensitive param-
eters. These highly sensitive reactions are enlisted below in table 4.4.
4.5 Edge Coupling Study
Edge coupling study was done on the network according to the scheme defined
in chapter 3.2.2. Most of the proteins in the model, have a translational compo-
nent built in the model along with a degradation component. The approach is to
remove one reaction at a time and see how its effect is felt by the other species in
the system. In the current model with 964 reactions, all of these reactions were
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removed, one at a time, and the effect on the components was observed. The
effect could be either upregulation or downregulation of a species or no effect
at all. This gives us a computational equivalent of the knockout studies done in
the wet experiments.
We sorted out the most important reactions, by using the most sensitive reac-
tions according to the data of the sensitivity study. The approach used here was
to cluster the values using k-means clustering. K-means clustering was done
to divide the sensitivity values to 2 clusters. The cluster with the higher mean
was picked and the elements of this cluster as tabulated in 4.4, was the subject
of study for the coupling studies.
The figure 4.17 denotes the coupling studies of the 26 highly sensitive nodes
of the UPR network. The color coding of the graph is binary, where green is up-
regulated and blue is downregulated. We find that all of these sensitive knock-
outs, leads to the upregulation of certain species (5 -BiP,11-eIF2α,51-Bim,54-
Bcl2,72-ATF6,76-S1P and 78-S2P). Edge removal of reaction 112 (Formation of
ATP) and 250 (Formation of the Ribosome) leads to the widespread effect over
all the species. Reaction 250 removal leads to overall downregulation of the
species. These results are consistent with our current understanding of the sys-
tem.
Bcl2 is upregulated to counteract the effect of UPR. This is seen in the form
of upregulation of species 54, in the coupling studies. If the formation of ATP is
hindered, there is a breakdown of the ERAD machinery of UPR. This clearly has
a widespread effect over the entire UPR functioning. This is correctly predicted
by the coupling studies. It is interesting to note that amongst the entire apop-
totic machinery, only the Bcl2 and Bim are points of concern. Further studies on
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Figure 4.17: This figure shows the results of coupling studies for the 26
highly sensitive reactions as obtained from the sensitivity
studies. Blue color denotes downregulation while green in-
dicates upregulation of the species indicated on the y axis.
An interesting result here shows that knockout of reaction 250
(production of the ribosome) leads to widespread downregu-
lation of all the species involved in the UPR network.
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this model might explain this better.
We have been successful, in modeling the UPR network to some extent. It is
providing the right trends of the species as seen in literature. It is encouraging to
find that sensitivity studies and coupling studies are providing the anticipated
outcomes. It shall be interesting to couple this network with other models, like
that of Hypoxia and Inflammatory response of a cell.
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CHAPTER 5
SUMMARY AND FUTURE DIRECTIONS
Overall we have developed an ensemble of models that is qualitatively rep-
resentative of the unfolded protein response. There are 964 reactions and 521
species in the model. Most of the data that was used to formulate the model,
were from different cell lines. The canonical ensemble of models, presents us
with a family of models that describe qualitatively the process over the diverse
data-sets.
However, this model does not include the survival aspects of UPR. There are
several anti-apoptotic pathways, including the NF-κB pathway, mTOR pathway
and the role of autophagy that is not included in the model. The connection of
translation to caspases is also not present in the model.
Two strategies were used to address the diversity of the models. The low
diversity or the localized search around the nominal set provided an ensemle of
models with 968 parameter sets. This case has an average Cv of 0.3. The high
diversity or the wide area search of the parameter space provided an ensemble
with 4200 parameters and an average Cv of 1.0. These ensembles are dependent
on the optimization scheme. This gives us the opportunity to test the effect of
temperature and weighted use of the objective functions in the future work.
Analysis of the models revealed results that were consistent with the litera-
ture as well as some new information. Sensitivity analysis revealed the impor-
tance of HSP40 in the UPR. Initiation of UPR by dissociation of BiP is relatively
important. This gives us motivation to test the other alternative source of acti-
vation of UPR. However the current analysis was based on the nominal set. A
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deeper analysis could be obtained by looking over the ensemble of models.
Coupling studies puts light on the importance of translation in the model.
However in the current model, translation is in a simplified form. We need to
incorporate the translation aspects into the model. The key role of ATP depen-
dent steps in the model. This study is done on the nominal set and needs to be
done over the entire ensemble.
So at the current state we prioritize our work into two broad areas. Our first
task is to include surivival aspects of UPR along with other related pathways.
Once we have a functionally complete model, we shall employ this model to
study Hypoxia, wherein UPR plays a major role.
5.1 Completing the UPR model: Inclusion of survival aspects
In the step towards having a complete model of UPR, we need to incorporate
some major pathways including NF-κB pathway, mTOR pathway and the AKT
pathway. Currently in our group we have a functioning model of the AKT and
mTOR activation which has been studied in the translation model. We shall
begin with incorporating this aspect into the UPR network and build on it, to
include the other downstream effects of AKT. Some other key areas that we have
identified to include into the model are listed in the following sub sections.
5.1.1 Inflammatory response and UPR
UPR and the inflammatory response are connected through several modalities.
UPR marks the increase in Reactive Oxygen Species (ROS), the increase in the
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release of Ca2+ from the ER, activation of transcription factor nuclear factor - κB
(NF-κB) and the mitogen-activated protein kinase, JUN N-terminal kinase (JNK)
[233].
Oxidative Stress
Oxidative stress is marked by the accumulation of Reactive oxygen species
(ROS). ROS are small molecules that are highly reactive due to the presence
of unpaired electrons. Protein folding requires energy and oxygen for the for-
mation of intramolecular and intermolecular disulphide bonds [200]. During
disulphide bond formation, protein disulphide isomerase (PDI) and ER oxi-
doreductin 1 (ERO1) play a key role as seen in figure 5.1. PDI accepts electrons
leading to the formation of disulphide bonds. ERO1 is involved in removal of
the electrons from the PDI to the molecular oxygen. Use of oxygen as the termi-
nal recipient of electrons lead to the generation of ROS [199]. Increase in load of
protein folding leads directly to the increase in ROS.
Cells mediate the accumulation of ROS in the cells using the UPR pathways.
The PERK pathway of UPR leads downstream to the phosphorylation of NRF2
(nulcear-factor-erythroid-derived 2 (NF-E2)-related factor 2) [64, 28]. Phospho-
rylated NRF2 translocates to the nucleus and leads to the transcription of antiox-
idant and oxidant-detoxifying enzymes like NAD(P)H-quinone oxidoreductase,
haem-oxygenase 1 and glutathione S-transferase [115, 231]. It also leads to the
increase in transcription of glutathione which aids in maintaining the redox
state of the cell [64, 28, 27]. PERK−/− cells lead to the accumulation of ROS
in comparison to PERK+/+ cells [64, 27]. ROS mediate inflammation [156].
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Figure 5.1: UPR and Inflammatory response: Formation of disulphide
bonds is a key step in the folding of the protein correctly in
the ER. The enzyme PDI accepts electrons from the folding pro-
teins leading to the oxidation of the thiol (SH) groups. This step
mediates the formation of the disulphide bonds. ERO1 in asso-
ciation with FAD transfers electrons from the PDI to molecular
Oxygen. This results in the formation of the hydrogen perox-
ide (ROS). Upon UPR induction, PERK downstream leads to
translation attenuation which leads to lower concentration of
IκB. Simultaneously the IRE1 branch of UPR leads to phospho-
rylation of IκB which leads to release of NF-κB. Phosphorylated
IκB is targeted for degradation and free NF-κB goes to the nu-
clei where it activates the inflammatory genes. IRE1 also leads
to the activation of the JNK pathway which leads to the activa-
tion of AP1 which goes to the nuclei to activate the inflamma-
tory genes. The ROS produced during UPR leads to the release
of Ca2+ from the ER through the ER-based Ca2+ channels. This
excess of Ca2+ in the ER migrates to the mitochondria where
it further leads to the production of ROS. This alteration in ER
Ca2+ homeostasis leads to further ER stress.
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NF-κB and PERK crossover
NF-κB plays a central role in inflammation [163]. Normally NF-κB is present
in the inactive state stably bound to the inhibitor of NF-κB (IκB). UPR leads to
phosphorylation and subsequent degradation of IκB. This allows the activation
of NF-κB and subsequent transport to the nucleus and transcription of several
inflammatory genes. There is evidence to suggest that release of calcium into
the cytosol during UPR might have a role in the activation of NF-κB [35]. There
could be a direct role of PERK branch of UPR by attenuating translation of in-
hibitors of NF-κB [34].
Role of IRE1α and NF-κB and JNK
The IRE1α-TRAF2 complex leads to the phosphorylation of IκB and thereby the
nuclear translocation of NF-κB [75] as seen in figure 5.1. The IRE1α-TRAF2 com-
plex also leads to the activation of protein kinase JNK. Activated JNK leads
to the phosphorylation of transcription factor activator protein 1 (AP1) which
leads to the expression of inflammatory genes [30]. The exact machinery in-
volved in the inflammatory response is yet not well understood.
All of this information is from a varied set of experiments that have been
over a diverse set of cell lines. Our next step is to conduct laboratory experi-
ments to test the validity of the interactions in the mammalian cancer cell lines
like HL-60 or LNCaP.
79
5.2 Study the role of UPR in Hypoxia
Once we have a functioning model of UPR with the survival aspects incorpo-
rated in it, we shall study the role of UPR in Hypoxia. ER not only acts as
the center for maturation of proteins, but also a center for oxygen sensing and
signaling. This enables a critical role of the ER in Hypoxic cell conditions. De-
privation of O2 has recently been shown to be an initiator of UPR.
It has been seen that Hypoxia leads to PERK activation and downstream
phosphorylation of eIF2α [91]. This effect is seen to occur in time scale of
minutes, in case of anoxic conditions. Under moderate hypoxia conditions i.e.
(1%) O2, we see that this response is a bit slower [90]. It is interesting to note
that eIF2α shows a transient response [90, 91, 112]. The importance of PERK
pathway was demonstrated in PERK−/− MEF’s. PERK knockout mice show
increased occurrence of apoptosis in contrast to their wild-type counterparts
[91, 10].
Hypoxia is associated with growing tumors. This gives the idea that in case
of tumors we see glucose deprivation, amino acid deprivation and oxidative
stress along with oxygen shortage which lead to ER stress and UPR [232]. It
has also been noted that XBP1 splicing takes place, which gives reason to be-
lieve that IRE1 branch of UPR is activated as well [164]. These evidence do not
provide a mechanism connecting UPR and Hypoxia, but does provide evidence
of initiation and importance of UPR in apoptosis. This presents an unique op-
portunity to investigate the critical role of UPR in a tumor cell. It is also noted
that UPR and mTOR play a critical role in controlling the UPR signal in case of
tumors and cancer cells.
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Our hypothesis is that UPR and translation plays a key role in the Hypoxic
cell. We shall test this hypothesis in a bone derived cell line. We plan to investi-
gate the activation of mTOR and AKT activation unpon induction of Hypoxia.
To test the importance of translation, we shall test the phosphorylation status of
4E-BP1 and eIF4E. We shall test the link of translation to a hypoxic cell. For test-
ing we shall conduct transcription factor arrays to track gene expression shifts.
The changes in mRNA shall be validated by qRT-PCR. Alterations in protein
concentrations shall be tested by western blot studies.
Besides Hypoxia, UPR is seen to be relevant in many other diseases. Some
of the key relations are discussed in the following sections.
5.3 Relevance of UPR in other diseases
ER stress plays a key role in diseases ranging from neurodegenration, cardiac
diseases, cancer, diabetes, hypoxia to muscle degeneration. Some of the key
diseases having a role of ER stress is demarcated in 5.2. Proper understanding of
the mechanisms involved in the above mentioned diseases presents an unique
opportunity for targets of potential drug discovery 5.3. We shall take a deeper
look at some of these disorders and see the currently understood role of UPR
and UPR-mediated apoptosis in these diseases.
5.3.1 Cardiac ailments
Recently diseases like myocardial ischaemia, cardiac hypertrophy, atherosclero-
sis and heart failure have are shown to have a defining role of UPR [52]. ER
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Table 5.1: ER stress-related diseases
Disease Relevance of ER Stress Protein of inter-
est
Alzheimer’s
disease (AD)
AD-induced Presenilin 1 induces ER
stress with suppressed protective
UPR signaling
Presenilin,
PERK-eIF2α
[202, 83, 189,
122, 135]
Parkinson’s dis-
ease (PD)
Suppressed ER-stress-induced apop-
tosis, parkin expression controlled by
ER stress
Parkin, α-
synuclein
[31, 187, 76, 151,
166]
Amyotrophic
lateral sclerosis
Interference of ERAD machinery, acti-
vation of ASK1
SOD, ASK1
[133]
Stroke ER stress induction in neurons acti-
vating UPR and apoptosis associated
with CHOP induction and ASK1 acti-
vation
PERK-eIF2α ,
ASK1 [188, 217,
206, 216, 95,
150, 186]
Bipolar Disor-
der
Medications induce UPR XBP1 polymor-
phisms [81, 21,
80]
Heart Disease UPR leads to degeneration of car-
diac myocytes, transaortic constric-
tion and myocardial infarction in-
duces UPR
ASK1
[53, 138, 193,
180, 145, 207]
82
Table 5.2: ER stress-related diseases
Disease Relevance of ER Stress Protein of inter-
est
Atherosclerosis ER stress induced in vascular cells IRE1 pathway
[50, 107, 230,
100, 61, 100]
Type 1 diabetes Impaired PERK pathway leads to
type 1 diabetes
PERK-eIF2α
[168, 3, 45, 218,
77, 143, 142]
Type 2 diabetes Obesity leads to ER stress leading to
Insulin resistance
XBP1 and JNK
[144]
Cancer Protective branches of UPR are upreg-
ulated
GRP78, XBP1,
PERK [181, 48,
79, 164, 11]
Autoimmune
disease
UPR leads to autoantigen production GRP78, HLA-
B27 [197, 13, 24]
stress in cardiac hypertrophy models have shown consistent occurance [138].
Expression of XBP1, GRP78 and PDI is shown consistently in these models [?].
It has been argued that induction of GRP78 leads to the preconditioning of the
heart which provides subsequent protection from further challenges [180, 207].
It has been shown that ASK1 activity increases in mice after aortic constriction
and during myocardial infarction [219]. So the ASK1 has a significant role in the
myocardiocyte cell death [116].
PUMA [131] gene studies, which also leads to pro-apoptotic signaling shows
significant roles in cardioprotection [198]. An interesting thing to note here is the
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role of p53 as it is shown to induce the activity of PUMA involving a key role of
p73 which is a related transcription factor (ramadan,terrinoni,melino).
ATF6α has been shown to be cardioprotective [114]. The cells that have high
expression of ATF6α have better functional recovery and also less apoptotic
and necrotic death [114]. ER stress is initiated in vascular cells due to Hyperc-
holesterolaemia and elevated triglycerides. This leads to cytokines production
downstream as shown in the endothelial cells [50]. CHOP plays a vital role in
expression of cytokines, thus showing a significant role of atherosclerosis [107].
Vascular endothelial cells lead to induction of ER stress due to high-protein di-
ets which create a by-product called Homocysteine [230]. XBP1 has been shown
to regulate lipogenesis and leads to activation of ER stress and dyslipidaemias
[100]. Overall ER stress has significant role to play in atherosclerosis.
5.3.2 Diabetes
In type I diabetes, the pancreatic β cells secrete large amounts of insulin and
glycoproteins. It has been shown that PERK deficient mice are more prone to
diabetes and progressive hyperglycemia [61]. Pancreatic β cells have shown that
the NO-induced apoptosis is CHOP dependent [143].
Type II diabetes is caused due to insulin resistance. PERK phosphorylation,
EIF2α phosphorylation and upregulation of GRP78 have been noted in high-
fat diet studies of mice liver and adipose tissue. JNK activation, which occurs
downstream of the ER stress pathway plays a major role in insulin resistance.
The course which we might choose to target is to reduce the JNK activation. We
could also try to increase the chemical chaperones in the cytoplasm to increase
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the sensitivity to insulin [144].
5.3.3 Cancer
ER stress and role of UPR and UPR-mediated apoptosis seem to be gaining
grounds in being important in tumors and cancer. GRP78 and XBP1 are seen to
be overexpressed in tumors in vivo and in hypoxic cancer cells [181, 48]. Gen-
erally in hypoxic regions of tumor cells and cancerous cells, UPR functions as
a protective mechanism. Less tumorigenic activity has been noted in GRP78-
deficient fibrosarcoma cells and XBP1-deficient and PERK-deficient mouse fi-
broblasts [79, 164, 11].
PERK and IRE1 thus present themselves as ideal targets in cancer therapy.
Versipelostatin, a compound that controls the rise of GRP78 protein has been
shown to produce antitumor activity in tumor xenograft models [148]. In-
terleukin 24 (IL24), a cytokine that binds with GRP78 is another possible tar-
get for antitumor activity [36]. Another aspect of UPR, proteasome inhibi-
tion plays a key role in tumor-related apoptosis. Antitumor acivity has been
seen in pancreatic cancers in the preclinical studies of bortezomib (Velcade;
Millennium/Janssen-Cilag) [129, ?]. Nelfavir (Viracept; Pfizer) and atazanavir
(Reyataz; Bristol-Myers Squibb) have been shown to induce UPR markers like
GRP78 and CHOP in malignant gliomas. This leads to the triggering of apop-
tosis [155]. HIV protease inhibitors lead to inhibition of the proteasome leading
to ER stress. p-53 independant apoptosis is seen to be induced by the induction
of GRP78, CHOP due to the action of Brefeldin A [18].
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5.3.4 Immune disorders
Plasma cells rely heavily on the role of UPR which is seen in XBP1 defficient
mice which alters their homeostasis [162]. Bortezomib plays a key role here
as it leads to depletion of the plasma cells by inducing ER stress. XBP1 def-
ficiency leads to drastic reductions in the amount of dendritic cell numbers in
mice [78]. Unfolded protein accumulation and UPR-induction has been noted in
autoimmune diseases like rheumatoid arthritis, imflammatory bowel diseases
and multiple sclerosis. UPR has a key role to play in autoimmunity.
It has been shown that B-cells and other cells of the immune system rely
on an intact UPR [197]. CREBH, an ER-membrane bound transcription factor
is structurally similar to ATF6 [141]. Upon ER stress CREBH transmigrates to
the Golgi and undergoes cleavage by S1 and S2 proteases. This cleavage re-
leases an N-terminal fragment that migrates to the nucleus [234]. It is seen
that upon knockdown of the CREBH in hepatocytes, there is reduction in the
mRNA encoding C-reactive protein and serum amyloid P-component. Both of
these proteins are associated with innate immune response [234]. It is also seen
that UPR and CREBH are induced by pro-inflammatory cytokines like IL-6 and
IL-1β [234].
UPR and autoimmunity may work together using the following schemes:
• Recognition of misfolded proteins by autoreactive immune cells.
• Release of neo-autoanitgens and UPR related autoantigens by cells under
ER stress.
• Cells under UPR lead to perturbation of immune-tolerance mechanisms
leading to further autoimmunity.
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Figure 5.2: UPR and its role in autoimmunity: BiP specific antibodies have
been seen in patients with rheumatoid arthritis and mouse
model of Sjogren’s syndrome. This suggests that UPR-specific
genes may act as autoantigens. UPR in the epithelium leads to
development of Colitis, atherosclerosis. These variable roles of
UPR can promote autoimmunity.
• Developing resistance to UPR-mediated apoptosis and leading to en-
hanced ERAD.
Humans and rodents with autoimmune diseases have been shown to elicit
autoreactive B- and T-cell response due to HSP’s and BiP. It was seen that pa-
tients with rheumatoid arthritis have 80% more antibodies for BiP than patients
with other rheumatic conditions [13]. Stress proteins act as an immune adjuvant
and elicit immune response [12].
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Pathogenesis of atherosclerosis involves inflammatory pathways with a crit-
ical role of UPR [59]. Elevation of IL-6 can be attributed to activation of p38
MAPK and is CHOP dependent [107]. In inflammatory atherosclerosis lesions,
oxidized phosphorylcholine induces the ATF4 and XBP1 UPR pathways along
with IL-6 by aortic endothelial cells [50].
The vast links of UPR with several diseases provide us with unique opportu-
nities to extend the study of the model. We shall aim to formulate the individual
models of these diseases and prioritize experiments targeted to these systems.
We hope to be able to identify targets for drug discovery for these systems, us-
ing sensitivity and coupling studies. The scale of these models also provide us
opportunity to create new tools to aid in the analysis of these models.
88
Table 5.3: ER stress and drug discovery
Compound Pathway tar-
geted
Role
Valporate,
lithium
ER chaperone
inducers
Used as mood stabilizers to induce
ER chaperones in case of Neuropro-
tection [15, 70, 172]
BIX ER Chaperone
Inducers
Used as a small-molecule inducer of
GRP78 in case of Celebral ischemia,
stroke [94]
Salubrinal PERK-eIF2α
pathway
Used as an agonist of PERK-eIF2α
pathway in case of Parkinson’s dis-
ease and stroke [168, 16, 161, 95, 61, 3]
p38 MAPK an-
tagonists
p38 MAPK
(CHOP activ-
ity)
Used to prevent p38 depen-
dent CHOP phosphorylation
in case of stroke, diabetes
[225, 210, 122, 150, 186]
Versipelostatin GRP78 Used in case of Cancer [148]
Bortezomib,
nelfavir,
atazanavir
Proteasome Used to kill auto-antibody-producing
plasma cells and multiple myeloma
cells in case of cancer and autoim-
mune disorders [99, 155, 51, 130]
Brefeldin A,
breflate
ADP-
ribosylation
factor
Used in case of leukaemia [152, 18]
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APPENDIX A
TABLE OF THE REACTIONS IN THE MODEL
In the following table, we have provided all the reactions that have been
modeled with the corresponding rate constants for the nominal set. This nomi-
nal set was obtained by hand-fitting the model to the experimental observations
made in the literature.
90
Table A.1: Reactions in UPR with their corresponding reaction rates
Reaction K f Kb Kcat
[] PROT – – 0.1
HSP 40+PROT PROT HSP 40 2.0 5.0 –
PERK+BiP PERK BiP 5.0 10.0 –
PERK BiP+PROT HSP 40+ATP BiP ATP PROT HSP 40+PERK f 2.0 0.2 –
2*PERK f PERK d 1.0 0.8 –
eIF2a+PERK d eIF2a comp 0.5 0.8 –
eIF2a comp eIF2a p+PERK d 1.0 1.2 –
eIF2a p ATF4 prod – – 0.8
ATF4 prod ATF4+eIF2a p – – 0.8
ATF4+ATF3 ATF3 act ATF4 – – 0.7
ATF3 act ATF4 ATF3 act+ATF4 – – 0.8
ATF3 act GADD34 complex – – 0.6
GADD34 complex GADD34+ATF3 act – – 0.7
GADD34+PP1a GADD34 PP1a 0.7 0.3 –
GADD34 PP1a+eIF2a p GADD34 PP1a eIF2a p 0.6 0.3 –
GADD34 PP1a eIF2a p eIF2a+GADD34 PP1a 0.7 0.3 –
IRE1 TITPKE+BiP IRE1 TITPKE BiP 5.0 12.0 –
IRE1 TITPKE BiP+PROT HSP 40+ATP BiP ATP PROT HSP 40+IRE1 TITPKE f 1.8 0.2 –
2*IRE1 TITPKE f IRE1 dimer 2.5 0.4 –
IRE1 dimer IRE1 act 0.5 2.0 –
IRE1 dimer+Bak IRE1 act 0.3 1.0 –
mRNA XBP1+IRE1 actmRNA XBP1 spliced complex – – 0.8
mRNA XBP1 spliced complexmRNA XBP1 spliced+IRE1 act – – 0.8
XBP1+NFY XBP1 NFY 0.6 1.1 –
XBP1 NFY+UPRE XBP1 NFY UPRE 0.4 1.1 –
XBP1 NFY+ERSE XBP1 NFY ERSE 0.4 1.1 –
IRE1 act+TRAF2 IRE1 act TRAF2 0.2 1.0 –
IRE1 act TRAF2+ASK1 IRE1 act TRAF2 ASK1 0.5 1.0 –
continued on next page
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Reaction K f Kb Kcat
IRE1 act TRAF2 ASK1 IRE1 act TRAF2+ASK1 act 0.4 1.0 –
JNK+ASK1 act JNK ASK1 act 1.0 2.0 –
JNK ASK1 act JNK act+ASK1 act 0.5 0.5 –
p38MAPK+ASK1 act p38MAPK ASK1 act 1.0 2.0 –
p38MAPK ASK1 act p38MAPK act+ASK1 act 0.5 0.5 –
Bim+JNK act Bim JNK act 1.0 0.3 –
Bim JNK act JNK act+Bim p – – 2.0
JNK act+Bcl2 JNK Bcl2 – – 0.5
ERSE [] – – 0.3
TRAF2 [] – – 0.3
JNK [] – – 0.3
ASK1 [] – – 0.3
p38MAPK [] – – 0.3
[]mRNA ERSE – – 0.2
mRNA ERSE+Ribosome Rm ERSE 0.2 0.1 –
Rm ERSE Ar ERSE – – 0.2
Ar ERSE ERSE+Ribosome – – 0.2
[]mRNA TRAF2 – – 0.2
mRNA TRAF2+Ribosome Rm TRAF2 0.2 0.1 –
Rm TRAF2 Ar TRAF2 – – 0.2
Ar TRAF2 TRAF2+Ribosome – – 0.2
[]mRNA JNK – – 0.4
mRNA JNK+Ribosome Rm JNK 0.4 0.2 –
Rm JNK Ar JNK – – 0.4
Ar JNK JNK+Ribosome – – 0.4
[]mRNA ASK1 – – 0.4
mRNA ASK1+Ribosome Rm ASK1 0.4 0.2 –
Rm ASK1 Ar ASK1 – – 0.4
Ar ASK1 ASK1+Ribosome – – 0.4
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Reaction K f Kb Kcat
[]mRNA p38MAPK – – 0.2
mRNA p38MAPK+Ribosome Rm p38MAPK 0.2 0.1 –
Rm p38MAPK Ar p38MAPK – – 0.2
Ar p38MAPK p38MAPK+Ribosome – – 0.2
ATF6a+BiP ATF6a BiP 5.0 15.0 –
ATF6a BiP+PROT HSP 40+ATP BiP ATP PROT HSP 40+ATF6a f 1.5 0.4 –
ATF6a f ATF6a g 2.0 0.1 –
ATF6a g+S1P ATF6a S1P 2.0 0.3 –
ATF6a S1P+S2P ATF6 CNTP 1.0 0.2 –
ATF6 CNTP ATF6 c n 0.8 0.1 –
ATF6 c n+ATF ATF6 ATF 1.0 0.4 –
ATF6 ATF+NFY ATF6 ATF NFY 0.5 1.4 –
ATF6 ATF NFY+ERSE1 ATF6 ATF NFY ERSE1 0.5 2.4 –
ATF6 ATF+ERSE2 ATF6 ATF ERSE2 1.3 3.5 –
[] ATP – – 10.0
[]mRNA BiP – – 10.0
mRNA BiP+Ribosome Rm BiP 10.0 0.5 –
Rm BiP Ar BiP – – 10.0
Ar BiP BiP+Ribosome – – 10.0
[]mRNA HSP 40 – – 20.0
mRNA HSP 40+Ribosome Rm HSP 40 20.0 0.5 –
Rm HSP 40 Ar HSP 40 – – 20.0
Ar HSP 40 HSP 40+Ribosome – – 20.0
[]mRNA NEF – – 0.0
mRNA NEF+Ribosome Rm NEF 0.0 0.0 –
Rm NEF Ar NEF – – 0.0
Ar NEF NEF+Ribosome – – 0.0
[]mRNA PERK – – 10.0
mRNA PERK+Ribosome Rm PERK 10.0 0.1 –
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Reaction K f Kb Kcat
Rm PERK Ar PERK – – 10.0
Ar PERK PERK+Ribosome – – 10.0
[]mRNA eIF2a – – 10.0
mRNA eIF2a+Ribosome Rm eIF2a 10.0 0.1 –
Rm eIF2a Ar eIF2a – – 10.0
Ar eIF2a eIF2a+Ribosome – – 10.0
[]mRNA ATF3 – – 0.5
mRNA ATF3+Ribosome Rm ATF3 0.5 0.1 –
Rm ATF3 Ar ATF3 – – 0.5
Ar ATF3 ATF3+Ribosome – – 0.5
[]mRNA PP1a – – 0.3
mRNA PP1a+Ribosome Rm PP1a 0.3 0.1 –
Rm PP1a Ar PP1a – – 0.3
Ar PP1a PP1a+Ribosome – – 0.3
[]mRNA Nrf2 – – 0.3
mRNA Nrf2+Ribosome Rm Nrf2 0.3 0.1 –
Rm Nrf2 Ar Nrf2 – – 0.3
Ar Nrf2 Nrf2+Ribosome – – 0.3
[]mRNA Keap1 – – 0.3
mRNA Keap1+Ribosome Rm Keap1 0.3 0.1 –
Rm Keap1 Ar Keap1 – – 0.3
Ar Keap1 Keap1+Ribosome – – 0.3
[]mRNA P2CE – – 0.3
mRNA P2CE+Ribosome Rm P2CE 0.3 0.1 –
Rm P2CE Ar P2CE – – 0.3
Ar P2CE P2CE+Ribosome – – 0.3
[]mRNA IRE1 TITPKE – – 10.0
mRNA IRE1 TITPKE+Ribosome Rm IRE1 TITPKE 10.0 0.1 –
Rm IRE1 TITPKE Ar IRE1 TITPKE – – 10.0
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Ar IRE1 TITPKE IRE1 TITPKE+Ribosome – – 10.0
[]mRNA Bak – – 0.5
mRNA Bak+Ribosome Rm Bak 0.5 0.1 –
Rm Bak Ar Bak – – 0.5
Ar Bak Bak+Ribosome – – 0.5
[]mRNA XBP1 – – 0.2
mRNA XBP1+Ribosome Rm XBP1 0.2 0.1 –
mRNA XBP1 spliced+Ribosome Rm XBP1 1.8 0.2 –
Rm XBP1 Ar XBP1 – – 0.2
Ar XBP1 XBP1+Ribosome – – 0.2
[]mRNA UPRE – – 0.2
mRNA UPRE+Ribosome Rm UPRE 0.2 0.01 –
Rm UPRE Ar UPRE – – 0.2
Ar UPRE UPRE+Ribosome – – 0.2
[]mRNA ATF6a – – 3.0
mRNA ATF6a+Ribosome Rm ATF6a 3.0 0.1 –
Rm ATF6a Ar ATF6a – – 3.0
Ar ATF6a ATF6a+Ribosome – – 3.0
[]mRNA S1P – – 0.2
mRNA S1P+Ribosome Rm S1P 0.2 0.1 –
Rm S1P Ar S1P – – 0.2
Ar S1P S1P+Ribosome – – 0.2
[]mRNA S2P – – 0.2
mRNA S2P+Ribosome Rm S2P 0.2 0.1 –
Rm S2P Ar S2P – – 0.2
Ar S2P S2P+Ribosome – – 0.2
[]mRNA ATF – – 0.2
mRNA ATF+Ribosome Rm ATF 0.2 0.1 –
Rm ATF Ar ATF – – 0.2
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Reaction K f Kb Kcat
Ar ATF ATF+Ribosome – – 0.2
[]mRNA NFY – – 0.2
mRNA NFY+Ribosome Rm NFY 0.2 0.1 –
Rm NFY Ar NFY – – 0.2
Ar NFY NFY+Ribosome – – 0.2
[]mRNA ERSE1 – – 0.2
mRNA ERSE1+Ribosome Rm ERSE1 0.2 0.1 –
Rm ERSE1 Ar ERSE1 – – 0.2
Ar ERSE1 ERSE1+Ribosome – – 0.2
[]mRNA ERSE2 – – 0.2
mRNA ERSE2+Ribosome Rm ERSE2 0.2 0.1 –
Rm ERSE2 Ar ERSE2 – – 0.2
Ar ERSE2 ERSE2+Ribosome – – 0.2
ATP [] – – 0.3
BiP [] – – 0.5
HSP 40 [] – – 0.3
NEF [] – – 0.3
PERK [] – – 0.6
eIF2a [] – – 0.5
ATF4 [] – – 0.5
ATF3 [] – – 0.3
GADD34 [] – – 0.6
PP1a [] – – 0.3
Nrf2 [] – – 0.3
Keap1 [] – – 0.3
P2CE [] – – 0.3
IRE1 TITPKE [] – – 0.4
Bax [] – – 0.0
Bak [] – – 0.3
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XBP1 [] – – 0.7
UPRE [] – – 0.3
SAGA [] – – 0.3
KAR2 [] – – 0.3
PDII [] – – 0.3
ATF6a [] – – 0.4
S1P [] – – 0.2
S2P [] – – 0.2
ATF [] – – 0.2
NFY [] – – 0.2
ERSE1 [] – – 0.3
ERSE2 [] – – 0.3
Dol [] – – 0.2
PROT [] – – 0.1
[] Ribosome – – 10.0
eIF2a p [] – – 0.5
ATF3 act [] – – 0.2
IRE1 act TRAF2+CASP12 IRE1 act TRAF2 CASP12 0.8 1.0 –
IRE1 act TRAF2 CASP12 CASP12 act+IRE1 act TRAF2 0.8 1.0 –
2*ATF4+CEBP ATF4 hdimer 0.4 4.0 –
[]mRNA CEBP – – 0.2
mRNA CEBP+Ribosome Rm CEBP – – 0.2
Rm CEBP Ar CEBP – – 0.2
Ar CEBP CEBP+Ribosome – – 0.2
CEBP [] – – 0.4
ATF4 hdimer+mRNA GADD153mRNA GADD153 act comp – – 0.6
mRNA GADD153 act compmRNA GADD153 act+ATF4 hdimer – – 0.8
GADD153+CREB GADD153 CREB – – 0.4
mRNA Bcl2+GADD153 CREBmRNA Bcl2 weak 0.4 0.2 –
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[]mRNA CREB – – 0.2
mRNA CREB+Ribosome Rm CREB – – 0.3
Rm CREB Ar CREB – – 0.3
Ar CREB CREB+Ribosome – – 0.3
CREB [] – – 0.2
[]mRNA Bcl2 – – 2.0
mRNA Bcl2+Ribosome Rm Bcl2 2.0 0.1 –
mRNA Bcl2 weak+Ribosome Rm Bcl2 0.5 0.1 –
Rm Bcl2 Ar Bcl2 – – 2.0
Ar Bcl2 Bcl2+Ribosome – – 2.0
[]mRNA GADD153 – – 0.2
mRNA GADD153+Ribosome Rm GADD153 – – 0.2
mRNA GADD153 act+Ribosome Rm GADD153 – – 1.0
Rm GADD153 Ar GADD153 – – 0.2
Ar GADD153 GADD153+Ribosome – – 0.2
ASK1 act+Bcl2 ASK comp 0.2 0.1 –
ASK comp ASK1 act – – 0.1
JNK act+Bcl2 JNK comp 0.3 0.2 –
JNK comp JNK act – – 0.1
XBP1 NFY ERSE+bZIP XBP1 NFY ERSE comp 0.4 0.2 –
XBP1 NFY ERSE comp XBP1 NFY ERSE+bZIP act 0.3 0.1 –
bZIP act+mRNA BiPmRNA BiP act – – 0.3
mRNA BiP act+Ribosome Rm BiP 2.0 0.5 –
CASP12 act+ProCASP9 ProCASP9 casp12 comp 0.8 1.0 –
ProCASP9 casp12 comp CASP9+CASP12 act 0.8 1.0 –
[]mRNA ProCASP8 – – 0.5
mRNA ProCASP8+Ribosome Rm ProCASP8 0.5 0.1 –
Rm ProCASP8 Ar ProCASP8 – – 0.5
Ar ProCASP8 ProCASP8+Ribosome – – 0.5
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CASP8+ProCASP3 CASP8 ProCASP3 0.5 1.0 –
CASP8 ProCASP3 CASP8+CASP3 – – 0.4
[]mRNA ProCASP3 – – 0.5
mRNA ProCASP3+Ribosome Rm ProCASP3 0.5 0.1 –
Rm ProCASP3 Ar ProCASP3 – – 0.5
Ar ProCASP3 ProCASP3+Ribosome – – 0.5
CASP8+ProCASP6 CASP8 ProCASP6 0.5 1.0 –
CASP8 ProCASP6 CASP8+CASP6 – – 0.4
[]mRNA ProCASP6 – – 0.5
mRNA ProCASP6+Ribosome Rm ProCASP6 0.5 0.1 –
Rm ProCASP6 Ar ProCASP6 – – 0.5
Ar ProCASP6 ProCASP6+Ribosome – – 0.5
CASP8+ProCASP7 CASP8 ProCASP7 0.5 1.0 –
CASP8 ProCASP7 CASP8+CASP7 – – 0.4
[]mRNA ProCASP7 – – 0.5
mRNA ProCASP7+Ribosome Rm ProCASP7 0.5 0.1 –
Rm ProCASP7 Ar ProCASP7 – – 0.5
Ar ProCASP7 ProCASP7+Ribosome – – 0.5
ProCASP8+CASP3 ProCASP8 CASP3 0.6 1.0 –
ProCASP8 CASP3 CASP8+CASP3 – – 0.7
ProCASP8+CASP6 ProCASP8 CASP6 0.6 1.0 –
ProCASP8 CASP6 CASP8+CASP6 – – 0.7
ProCASP8+CASP7 ProCASP8 CASP7 0.6 1.0 –
ProCASP8 CASP7 CASP8+CASP7 – – 0.7
Bid c+CKI Bid CKI 0.5 0.1 –
Bid CKI P Bid c+CKI – – 0.4
[]mRNA Bid – – 0.3
mRNA Bid+Ribosome Rm Bid 0.3 0.1 –
Rm Bid Ar Bid – – 0.3
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Ar Bid Bid c+Ribosome – – 0.3
[]mRNA CKI – – 0.3
mRNA CKI+Ribosome Rm CKI 0.3 0.1 –
Rm CKI Ar CKI – – 0.3
Ar CKI CKI+Ribosome – – 0.3
[]mRNA CKII – – 0.2
mRNA CKII+Ribosome Rm CKII 0.2 0.1 –
Rm CKII Ar CKII – – 0.2
Ar CKII CKII+Ribosome – – 0.2
Bid c+CKII Bid CKII 0.3 0.2 –
Bid CKII P Bid c+CKII – – 0.3
Bid c+CASP8 Bid CASP8 0.4 1.5 –
Bid CASP8 t Bid c+CASP8 – – 0.5
PTP PTP open 0.2 1.0 –
Bak+PTP open Bak PTP open 0.3 2.0 –
Bak PTP open Bak+5*PTP open – – 0.5
Bcl2+PTP open Bcl2 PTP open 0.5 1.0 –
cytoc m+PTP open cytoc m PTP open 0.4 1.0 –
cytoc m PTP open PTP open+cytochromeC c – – 0.8
CAi+Bad inactive CAi Bad inactive – – 0.3
CAi Bad inactive CAi+Bad 0.3 0.6 –
Bcl2+Bak Bcl2 Bak 10.0 0.5 –
Bcl2 Bak+Bad Bak+Bcl2 Bad 0.3 0.7 –
Bcl2+Bak inactive Bcl2 Bak 0.0 0.0 –
Bad+Bak inactive Bak inactive Bad 0.0 0.0 –
Bak inactive Bad Bak+Bad 0.0 0.0 –
t Bid c+PTP open t Bid c PTP open 0.5 2.0 –
t Bid c PTP open t Bid c+5*PTP open – – 0.3
CrmA+Bid CASP8 CrmA Bid CASP8 0.8 0.4 –
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PTP open+Diablo m Diablo PTP open 0.4 1.8 –
Diablo PTP open Diablo c+PTP open – – 0.5
[]mRNA Diablo – – 0.2
mRNA Diablo+Ribosome Rm Diablo 0.2 0.1 –
Rm Diablo Ar Diablo – – 0.2
Ar Diablo Diablo m+Ribosome – – 0.2
PTP open+Omi m Omi PTP open 0.4 1.9 –
Omi PTP open Omi c+PTP open – – 0.4
[]mRNA Omi – – 0.2
mRNA Omi+Ribosome Rm Omi 0.2 0.1 –
Rm Omi Ar Omi – – 0.2
Ar Omi Omi m+Ribosome – – 0.2
PTP open+AIF m AIF PTP open 0.3 1.8 –
AIF PTP open AIF c+PTP open – – 0.4
[]mRNA AIF – – 0.2
mRNA AIF+Ribosome Rm AIF 0.2 0.1 –
Rm AIF Ar AIF – – 0.2
Ar AIF AIF m+Ribosome – – 0.2
PTP open+endoG m endoG PTP open – – 0.4
endoG PTP open endoG c+PTP open – – 0.4
[]mRNA endoG – – 0.1
mRNA endoG+Ribosome Rm endoG 0.1 0.01 –
Rm endoG Ar endoG – – 0.1
Ar endoG endoG m+Ribosome – – 0.1
Diablo c+IAP1 Diablo IAP1 0.3 0.1 –
Omi c+IAP1 Omi IAP1 0.4 0.1 –
AIF c AIF n 0.5 0.1 –
endoG c endoG n 0.5 0.1 –
AIF n+DNA intact AIF DNA intact 0.8 1.9 –
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AIF DNA intact AIF n+DNA degraded – – 0.6
endoG n+DNA intact endoG DNA intact 0.7 1.9 –
endoG DNA intact endoG n+DNA degraded – – 0.5
IAP1+CASP3 IAP1 CASP3 1.5 0.6 –
[]mRNA IAP1 – – 0.3
mRNA IAP1+Ribosome Rm IAP1 0.3 0.1 –
Rm IAP1 Ar IAP1 – – 0.3
Ar IAP1 IAP1+Ribosome – – 0.3
IAP1+CASP6 IAP1 CASP6 1.5 0.6 –
IAP1+CASP7 IAP1 CASP7 1.5 0.6 –
IAP2+CASP3 IAP2 CASP3 1.5 0.5 –
[]mRNA IAP2 – – 0.3
mRNA IAP2+Ribosome Rm IAP2 0.3 0.1 –
Rm IAP2 Ar IAP2 – – 0.3
Ar IAP2 IAP2+Ribosome – – 0.3
IAP2+CASP6 IAP2 CASP6 1.5 0.5 –
IAP2+CASP7 IAP2 CASP7 1.5 0.5 –
XIAP+CASP3 XIAP CASP3 1.5 0.4 –
[]mRNA XIAP – – 0.3
mRNA XIAP+Ribosome Rm XIAP 0.3 0.1 –
Rm XIAP Ar XIAP – – 0.3
Ar XIAP XIAP+Ribosome – – 0.3
XIAP+CASP6 XIAP CASP6 1.5 0.4 –
XIAP+CASP7 XIAP CASP7 1.5 0.4 –
XIAP+Omi c XIAP Omi c 0.5 0.1 –
Apaf1 Apaf1 p 0.0 0.0 –
7*cytochromeC c+7*Apaf1 p+7*ProCASP9 Apoptosome 0.0 0.0 –
7*cytochromeC c+7*Apaf1+7*ProCASP9 Apoptosome 0.9 1.5 –
[]mRNA Apaf1 – – 0.3
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mRNA Apaf1+Ribosome Rm Apaf1 0.3 0.1 –
Rm Apaf1 Ar Apaf1 – – 0.3
Ar Apaf1 Apaf1+Ribosome – – 0.3
[]mRNA ProCASP9 – – 0.5
mRNA ProCASP9+Ribosome Rm ProCASP9 0.5 0.1 –
Rm ProCASP9 Ar ProCASP9 – – 0.5
Ar ProCASP9 ProCASP9+Ribosome – – 0.7
Apoptosome 7*CASP9+7*cytochromeC c+7*Apaf1 – – 0.9
ProCASP3+CASP9 ProCASP3 CASP9 0.6 1.0 –
ProCASP3 CASP9 CASP9+CASP3 – – 0.7
ProCASP6+CASP9 ProCASP6 CASP9 0.6 1.0 –
ProCASP6 CASP9 CASP9+CASP6 – – 0.7
ProCASP7+CASP9 ProCASP7 CASP9 0.6 1.0 –
ProCASP7 CASP9 CASP9+CASP7 – – 0.7
ProCASP9+CASP3 ProCASP9 CASP3 0.5 1.0 –
ProCASP9 CASP3 CASP9+CASP3 – – 0.8
ProCASP9+CASP6 ProCASP9 CASP3 0.5 1.0 –
ProCASP9 CASP3 CASP9+CASP6 – – 0.8
ProCASP9+CASP7 ProCASP9 CASP7 0.5 1.0 –
ProCASP9 CASP7 CASP9+CASP7 – – 0.8
ProCASP8 [] – – 0.9
CASP8 [] – – 0.4
ProCASP3 [] – – 0.9
CASP3 [] – – 0.6
ProCASP6 [] – – 0.9
CASP6 [] – – 0.6
ProCASP7 [] – – 0.9
CASP7 [] – – 0.6
Bid c [] – – 0.4
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CKI [] – – 0.3
CKII [] – – 0.3
CrmA [] – – 0.2
Diablo m [] – – 0.2
Diablo c [] – – 0.4
Omi m [] – – 0.2
Omi c [] – – 0.4
AIF m [] – – 0.2
AIF c [] – – 0.4
endoG m [] – – 0.2
endoG c [] – – 0.4
IAP1 [] – – 0.2
AIF n [] – – 0.2
endoG n [] – – 0.2
DNA intact [] – – 0.3
IAP2 [] – – 0.2
XIAP [] – – 0.2
Apaf1 [] – – 0.3
ProCASP9 [] – – 0.9
CASP9 [] – – 0.5
[]mRNA Casper – – 0.2
mRNA Casper+Ribosome Rm Casper 0.2 0.1 –
Rm Casper Ar Casper – – 0.2
Ar Casper Casper+Ribosome – – 0.2
[]mRNA I FLICE – – 0.2
mRNA I FLICE+Ribosome Rm I FLICE 0.2 0.1 –
Rm I FLICE Ar I FLICE – – 0.2
Ar I FLICE I FLICE+Ribosome – – 0.2
[] DNA intact – – 0.5
continued on next page
104
continued from previous page
Reaction K f Kb Kcat
[]mRNA CrmA – – 0.3
mRNA CrmA+Ribosome Rm CrmA 0.3 0.1 –
Rm CrmA Ar CrmA – – 0.3
Ar CrmA CrmA+Ribosome – – 0.3
[]mRNA cytoc m – – 0.3
mRNA cytoc m+Ribosome Rm cytoc m 0.3 0.1 –
Rm cytoc m Ar cytoc m – – 0.3
Ar cytoc m cytoc m+Ribosome – – 0.3
[]mRNA Bad inactive – – 0.2
mRNA Bad inactive+Ribosome Rm Bad inactive 0.2 0.1 –
Rm Bad inactive Ar Bad inactive – – 0.2
Ar Bad inactive Bad inactive+Ribosome – – 0.2
[] PTP – – 0.5
[]mRNA VDAC – – 0.2
mRNA VDAC+Ribosome Rm VDAC 0.2 0.1 –
Rm VDAC Ar VDAC – – 0.2
Ar VDAC VDAC+Ribosome – – 0.2
[]mRNA UP – – 0.2
mRNA UP+Ribosome Rm UP 0.2 0.1 –
Rm UP Ar UP – – 0.2
Ar UP UP+Ribosome – – 0.2
[]mRNA cyclophilin D – – 0.2
mRNA cyclophilin D+Ribosome Rm cyclophilin D 0.2 0.1 –
Rm cyclophilin D Ar cyclophilin D – – 0.2
Ar cyclophilin D cyclophilin D+Ribosome – – 0.2
CA cytosol [] – – 0.2
VDAC [] – – 0.2
UP [] – – 0.2
cyclophilin D [] – – 0.2
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PTP [] – – 0.2
Bak [] – – 0.0
Bcl2 [] – – 0.1
cytoc m [] – – 0.2
Bad inactive [] – – 0.0
[] CA cytosol – – 0.2
CA external CAi – – 0.0
CASP8+BAP31 CASP8 BAP31 – – 0.4
CASP8 BAP31 BAP20+CASP8 – – 0.8
BAP20+CAs BAP20 CAs – – 0.3
BAP20 CAs BAP20+CAi – – 0.6
CAi CA external – – 0.0
[]mRNA CASP12 – – 1.0
mRNA CASP12+Ribosome Rm CASP12 1.0 0.1 –
Rm CASP12 Ar CASP12 – – 1.0
Ar CASP12 CASP12+Ribosome – – 1.0
CASP12 act [] – – 0.3
CASP12 [] – – 0.5
JNK act [] – – 0.3
ASK1 act [] – – 0.3
PTP open [] – – 0.4
cytochromeC c [] – – 0.4
CASP8+CASP3 CASP8 ProCASP3 – – 1.1
CASP8+CASP6 CASP8 ProCASP6 – – 1.1
CASP8+CASP7 CASP8 ProCASP7 – – 1.1
CASP8+CASP3 ProCASP8 CASP3 – – 1.1
CASP8+CASP6 ProCASP8 CASP6 – – 1.1
CASP8+CASP7 ProCASP8 CASP7 – – 1.1
P Bid c+CKI Bid CKI – – 1.5
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P Bid c+CKII Bid CKII – – 1.5
t Bid c+CASP8 Bid CASP8 – – 1.5
7*CASP9+7*cytochromeC c+7*Apaf1 Apoptosome – – 1.5
CASP9+CASP3 ProCASP3 CASP9 – – 1.0
CASP9+CASP6 ProCASP6 CASP9 – – 1.0
CASP9+CASP7 ProCASP7 CASP9 – – 1.0
CASP9+CASP3 ProCASP9 CASP3 – – 1.0
CASP9+CASP6 ProCASP9 CASP3 – – 1.0
CASP9+CASP7 ProCASP9 CASP7 – – 1.0
CASP3+GAS2 CASP3 GAS2 0.5 1.0 –
CASP3 GAS2 CASP3+t GAS2 0.4 1.0 –
[]mRNA GAS2 – – 0.2
mRNA GAS2+Ribosome Rm GAS2 0.2 0.1 –
Rm GAS2 Ar GAS2 – – 0.2
Ar GAS2 GAS2+Ribosome – – 0.2
GAS2 [] – – 0.2
CASP3+Fodrin CASP3 Fodrin 0.5 1.0 –
CASP3 Fodrin CASP3+t Fodrin 0.8 1.0 –
[]mRNA Fodrin – – 0.2
mRNA Fodrin+Ribosome Rm Fodrin 0.2 0.1 –
Rm Fodrin Ar Fodrin – – 0.2
Ar Fodrin Fodrin+Ribosome – – 0.2
Fodrin [] – – 0.2
CASP3+Gelsolin CASP3 Gelsolin 0.5 1.0 –
CASP3 Gelsolin CASP3+t Gelsolin 0.8 1.0 –
[]mRNA Gelsolin – – 0.2
mRNA Gelsolin+Ribosome Rm Gelsolin 0.2 0.1 –
Rm Gelsolin Ar Gelsolin – – 0.2
Ar Gelsolin Gelsolin+Ribosome – – 0.2
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Gelsolin [] – – 0.2
CASP6+LaminA CASP6 LaminA 0.7 1.0 –
CASP6 LaminA CASP6+t LaminA 0.8 1.0 –
[]mRNA LaminA – – 0.2
mRNA LaminA+Ribosome Rm LaminA 0.2 0.1 –
Rm LaminA Ar LaminA – – 0.2
Ar LaminA LaminA+Ribosome – – 0.2
LaminA [] – – 0.2
CASP3+LaminB1 CASP3 LaminB1 0.0 0.0 –
CASP3 LaminB1 CASP3+t LaminB1 0.0 0.0 –
[]mRNA LaminB1 – – 0.0
mRNA LaminB1+Ribosome Rm LaminB1 0.0 0.0 –
Rm LaminB1 Ar LaminB1 – – 0.0
Ar LaminB1 LaminB1+Ribosome – – 0.0
LaminB1 [] – – 0.0
CASP6+LaminC CASP6 LaminC 0.4 1.0 –
CASP6 LaminC CASP6+t LaminC 0.8 1.0 –
[]mRNA LaminC – – 0.2
mRNA LaminC+Ribosome Rm LaminC 0.2 0.1 –
Rm LaminC Ar LaminC – – 0.2
Ar LaminC LaminC+Ribosome – – 0.2
LaminC [] – – 0.2
CASP3+Nup153 CASP3 Nup153 0.5 1.0 –
CASP3 Nup153 CASP3+t Nup153 0.8 1.0 –
[]mRNA Nup153 – – 0.2
mRNA Nup153+Ribosome Rm Nup153 0.2 0.1 –
Rm Nup153 Ar Nup153 – – 0.2
Ar Nup153 Nup153+Ribosome – – 0.2
Nup153 [] – – 0.2
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CASP3+PARP CASP3 PARP 0.5 1.0 –
CASP3 PARP CASP3+t PARP 1.0 1.0 –
[]mRNA PARP – – 0.3
mRNA PARP+Ribosome Rm PARP 0.3 0.1 –
Rm PARP Ar PARP – – 0.3
Ar PARP PARP+Ribosome – – 0.3
PARP [] – – 0.6
CASP7+PARP CASP7 PARP 0.5 1.0 –
CASP7 PARP CASP7+t PARP 1.0 1.0 –
CASP9+PARP CASP9 PARP 0.5 1.0 –
CASP9 PARP CASP9+t PARP 1.0 1.0 –
CASP3+TopoI CASP3 TopoI 0.5 1.0 –
CASP3 TopoI CASP3+t TopoI 0.8 1.0 –
[]mRNA TopoI – – 0.2
mRNA TopoI+Ribosome Rm TopoI 0.2 0.1 –
Rm TopoI Ar TopoI – – 0.2
Ar TopoI TopoI+Ribosome – – 0.2
TopoI [] – – 0.2
CASP3+PolE CASP3 PolE 0.5 1.0 –
CASP3 PolE CASP3+t PolE 0.8 1.0 –
[]mRNA PolE – – 0.2
mRNA PolE+Ribosome Rm PolE 0.2 0.1 –
Rm PolE Ar PolE – – 0.2
Ar PolE PolE+Ribosome – – 0.2
PolE [] – – 0.2
CASP9+ICAD CASP9 ICAD 0.5 1.0 –
CASP9 ICAD CASP9+CAD 0.8 1.0 –
[]mRNA ICAD – – 0.3
mRNA ICAD+Ribosome Rm ICAD 0.2 0.1 –
continued on next page
109
continued from previous page
Reaction K f Kb Kcat
Rm ICAD Ar ICAD – – 0.2
Ar ICAD ICAD+Ribosome – – 0.2
ICAD [] – – 0.2
CAD+DNA intact CAD DNA intact 0.5 1.0 –
CAD DNA intact CAD+DNA degraded – – 0.5
t Fodrin [] – – 0.3
t GAS2 [] – – 0.3
t Gelsolin [] – – 0.3
t LaminA [] – – 0.3
t LaminB1 [] – – 0.3
t LaminC [] – – 0.3
t Nup153 [] – – 0.3
t PARP [] – – 0.3
t TopoI [] – – 0.3
t PolE [] – – 0.3
CAD [] – – 0.2
UB+ATP UB ATP 1.0 0.5 –
UB ATP+E1 SH E1 S UB+AMP+PPi 0.8 0.4 –
E1 S UB E2 S UB 0.7 0.3 –
E2 S UB+E3 E3 E2 S UB 0.7 0.2 –
PROT+E3 E2 S UB Prot degrad target 0.5 0.1 –
Prot degrad target [] – – 0.0
AMP [] – – 0.2
PPi [] – – 0.2
UB [] – – 0.3
E1 SH [] – – 0.2
E3 [] – – 0.2
[]mRNA UB – – 0.3
mRNA UB+Ribosome Rm UB 0.3 0.1 –
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Rm UB Ar UB – – 0.3
Ar UB UB+Ribosome – – 0.3
[]mRNA E1 SH – – 0.2
mRNA E1 SH+Ribosome Rm E1 SH 0.3 0.1 –
Rm E1 SH Ar E1 SH – – 0.2
Ar E1 SH E1 SH+Ribosome – – 0.2
[]mRNA E3 – – 0.3
mRNA E3+Ribosome Rm E3 0.3 0.1 –
Rm E3 Ar E3 – – 0.3
Ar E3 E3+Ribosome – – 0.3
ATF6 ATF NFY ERSE1+mRNA GADD153mRNA GADD153 act 1.0 1.5 –
ATF6 ATF ERSE2+mRNA GADD153mRNA GADD153 act 0.8 1.2 –
XBP1 NFY ERSE+mRNA GADD153mRNA GADD153 act 0.9 1.8 –
[]mRNA bZIP – – 0.2
mRNA bZIP+Ribosome Rm bZIP 0.2 0.1 –
Rm bZIP Ar bZIP – – 0.2
Ar bZIP bZIP+Ribosome – – 0.2
GADD153 [] – – 0.8
p38MAPK act [] – – 0.6
GADD153+p38MAPK act GADD153 p38MAPK act 0.9 1.4 –
GADD153 p38MAPK act GADD153 p+p38MAPK act 0.8 1.4 –
GADD153 p [] – – 0.6
CA cytosol+t Bid c CA BID complex – – 0.3
CA BID complex CAi+t Bid c – – 0.3
CAi+VDAC CA VDAC 0.3 0.6 –
CA VDAC CA OMM+VDAC 0.4 0.8 –
CA OMM+UP CA OMM UP 0.5 1.0 –
CA OMM UP CAm+UP 0.4 0.8 –
CAm CSMDH 1 0.3 0.6 –
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CSMDH 1 CSMDH+CAm 0.4 0.8 –
CAm+cyclophilin D CAm cyclophilin D 0.5 1.0 –
CAm ROS 1 0.4 0.6 –
ROS 1 ROS+CAm 0.5 0.8 –
CAm FFA 1 0.3 0.6 –
FFA 1 FFA+CAm 0.4 0.8 –
CAm cyclophilin D+PTP CAm cyclophilin D PTP 0.4 0.8 –
CAm cyclophilin D PTP CAm cyclophilin D+PTP open 0.8 1.5 –
IP3Ri+cytochromeC c IP3R comp 0.5 1.0 –
IP3R comp IP3R act+cytochromeC c 0.4 0.8 –
IP3Ri+Bak IP3R act 0.3 0.6 –
IP3R act+Bcl2 IP3Ri Bcl2 1.0 0.5 –
IP3R+IP3 IP3R IP3 0.3 0.3 –
IP3R IP3 IP3R IP3a 0.3 0.3 –
IP3R IP3a+CAi IP3R act 0.3 0.8 –
IP3R act+CAs IP3R CAs 0.4 0.8 –
IP3R CAs IP3R act+CAi 0.4 0.8 –
Bap31+Bcl2 Bap31 Bcl2 0.8 0.4 –
[]mRNA Bap31 – – 0.2
mRNA Bap31+Ribosome Rm Bap31 0.2 0.1 –
Rm Bap31 Ar Bap31 – – 0.2
Ar Bap31 Bap31+Ribosome – – 0.2
Bap31 [] – – 0.2
DRP1+CAi DRP1 CAi 0.3 0.3 –
DRP1 CAi DRP1 act+CAi 0.3 0.3 –
[]mRNA DRP1 – – 0.2
mRNA DRP1+Ribosome Rm DRP1 0.2 0.1 –
Rm DRP1 Ar DRP1 – – 0.2
Ar DRP1 DRP1+Ribosome – – 0.2
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DRP1 [] – – 0.7
DRP1 act [] – – 0.8
CAi+Plases inact CAi Plases 0.3 0.3 –
[]mRNA Plases inact – – 0.3
mRNA Plases inact+Ribosome Rm Plases inact 0.2 0.1 –
Rm Plases inact Ar Plases inact – – 0.3
Ar Plases inact Plases inact+Ribosome – – 0.2
Plases inact [] – – 0.4
CAi Plases m [] – – 0.3
CAi Plases CAi Plases m 0.3 0.3 –
Card in+CAi Plases m Card Plases 0.4 0.4 –
Card Plases Card out+CAi Plases m 0.5 0.5 –
[]mRNA Card in – – 0.3
mRNA Card in+Ribosome Rm Card in 0.3 0.2 –
Rm Card in Ar Card in – – 0.3
Ar Card in Card in+Ribosome – – 0.3
Card in [] – – 0.7
Card out [] – – 0.4
Bak+PTP open+Card out Bak PTP open Card out – – 0.3
Bak PTP open Card out Bak+5*PTP open+Card out – – 0.5
t Bid c+PTP open+Card out t Bid c PTP open Card out – – 0.3
t Bid c PTP open Card out t Bid c+5*PTP open+Card out – – 0.5
CAi+NOS CAi RNS 0.3 0.3 –
CAi RNS CAi+RNS 0.3 0.3 –
[] NOS 0.2 0.4 –
CAi+PTP open CAi PTP 0.6 0.8 –
CAi PTP CAi+5*PTP open 0.3 0.7 –
CAi+DAPK1 CA DAPK 0.3 0.3 –
CA DAPK CAi+DAPK act 0.4 0.4 –
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[]mRNA DAPK1 – – 0.2
mRNA DAPK1+Ribosome Rm DAPK1 0.2 0.1 –
Rm DAPK1 Ar DAPK1 – – 0.2
Ar DAPK1 DAPK1+Ribosome – – 0.2
DAPK1 [] – – 0.6
DAPK act [] – – 0.8
CAi+Calpain inact Calpain CA comp 0.3 0.3 –
Calpain CA comp Calpain act+CAi 0.3 0.4 –
[]mRNA Calpain inact – – 0.2
mRNA Calpain inact+Ribosome Rm Calpain inact 0.2 0.1 –
Rm Calpain inact Ar Calpain inact – – 0.2
Ar Calpain inact Calpain inact+Ribosome – – 0.2
Calpain inact [] – – 0.7
Calpain act [] – – 0.8
CAm [] – – 0.2
CAi [] – – 0.2
CAs [] – – 0.2
RNS [] – – 0.5
[]mRNA IP3R – – 0.3
mRNA IP3R+Ribosome Rm IP3R 0.3 0.1 –
Rm IP3R Ar IP3R – – 0.3
Ar IP3R IP3R+Ribosome – – 0.3
[]mRNA IP3 – – 0.2
mRNA IP3+Ribosome Rm IP3 0.2 0.1 –
Rm IP3 Ar IP3 – – 0.2
Ar IP3 IP3+Ribosome – – 0.2
IP3R act [] – – 0.7
IP3Ri [] – – 0.7
IP3R [] – – 0.7
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IP3 [] – – 0.8
CA BID complex CA cytosol+t Bid c – – 0.6
CAi+t Bid c CA BID complex – – 0.6
P Bid c+CKI Bid CKI – – 0.8
P Bid c+CKII Bid CKII – – 0.8
t Bid c+CASP8 Bid CASP8 – – 0.8
[] CAs – – 0.2
ATF4 prod eIF2a p – – 1.4
ATF4+eIF2a p ATF4 prod – – 1.0
ATF3 act ATF4 ATF4+ATF3 – – 1.0
ATF3 act+ATF4 ATF3 act ATF4 – – 1.0
GADD34 complex ATF3 act – – 1.0
GADD34+ATF3 act GADD34 complex – – 1.0
mRNA XBP1 spliced complexmRNA XBP1+IRE1 act – – 1.0
mRNA XBP1 spliced+IRE1 actmRNA XBP1 spliced complex – – 1.4
JNK act+Bim p Bim JNK act – – 2.0
JNK Bcl2 JNK act+Bcl2 – – 0.5
PTP+Bim JNK act PTP Bim JNK act 0.5 0.8 –
PTP Bim JNK act Bim JNK act+3*PTP open 0.4 0.8 –
[] CAs – – 0.2
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